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Summary 
 
Mitochondria are unique to have a multicopy genome, resulting in a 
substantially different fate of damaged DNA molecules in comparison to nuclear 
DNA. Damaged DNA usually represents only a small fraction of total 
mitochondrial DNA (mtDNA) in a cell, which can be removed, through DNA 
degradation, without severe consequences and get replaced by replication of 
intact mtDNA. This idea of a “disposable genome” plays an essential role for 
modern gene therapy of mitochondrial diseases, which aim to eliminate 
pathogenic mtDNA mutations by selectively breaking down mutated mtDNA. 
Introducing mtDNA double-strand breaks (DSB), elimination of paternal 
mtDNA or virus-induced mtDNA depletion are described phenomena of 
eliminating mtDNA. The molecular machinery performing mtDNA degradation 
is still unknown. This work used the CRISPR/Cas9 technique to create stable 
knockout and knockin cell lines of selected mitochondrial nucleases in a cellular 
model to study degradation of linear mtDNA. An induced expression of 
restriction endonuclease mitoEagI introduced DSB into the mitochondrial 
genome of living cells, linearizing it in the process. Inactivation of the 
mitochondrial 5’–3’ exonuclease MGME1 and the 3’–5’ exonuclease activity of 
POLG (a subunit of the mitochondrial DNA polymerase gamma), through 
introducing the p.D274A point mutation severely impaired rapid linear mtDNA 
degradation. Additional knockout cell lines of other mitochondrial nucleases 
(APEX2, EXOG) showed no deficiencies on linear mtDNA degradation. Along 
with recent findings, that the mitochondrial DNA helicase Twinkle is also 
involved in linear mtDNA degradation (Peeva and Blei et al., 2018), this 
altogether proposes novel, additional roles for the mtDNA replication 
machinery. 
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1. Introduction 
1.1 Morphology and function of mitochondria 
A mitochondrion consists of an outer and an inner membrane, with the 
intermembrane space in between. Its inner membrane surrounds the lumen of 
the mitochondrion, called matrix (Figure 1). The outer mitochondrial membrane 
(OMM) is built of a phospholipid bilayer harbouring a multitude of proteins, 
including a diverse set of enzymes, pore forming proteins (porins) and proteins 
mediating mitochondrial fusion and fission (Walther and Rapaport 2009). 
Porins provide permeability for the OMM allowing molecules of up to 5 kDa in 
molecular weight to cross it in both directions (Molecular Biology of the Cell, 
2011). The inner mitochondrial membrane (IMM) is a highly impermeable 
barrier, folded into so called cristae, which largely increase its surface area. 
Along the IMM aligns the electron transport chain (ETC), an assembly of protein 
complexes (I–IV) that reduce oxygen (O2) to build up a proton (H+) gradient from 
the matrix into the intermembrane space. The efficiency of these so called 
respiratory chain supercomplexes (RCS), which provide the functional roles of 
catalytic enhancement, substrate channelling and stabilization of complex I by 
complex III, is directly related to the shape and structure of the cristae, 
independently to changes of the mitochondrial protein synthesis or OMM 
permeabilization (Cogliati et al., 2013). 
Figure 1: The mitochondrion. (a) Scanning Electron Microscope (SEM) image of a cross 
section through a mitochondrion. (b) Schematic drawing of the three-dimensional structure of a 
mitochondrion, with a part cut out (figure adapted from Molecular Biology of the Cell, Fifth 
Edition by Alberts et al., 2011; German edition). 
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The reflux of protons from the intermembrane space back into the matrix occurs 
through the ATP synthase (complex V), incorporated at edges of the cristae. This 
part uses the potential energy in a reaction called oxidative phosphorylation 
(OXPHOS) to produce ATP from ADP and inorganic phosphate (Pi) inside the 
matrix (Figure 2). The matrix also contains a high concentration of proteins (2/3 
of the total mitochondrion), which, among other functions, play a role in forming 
the citric acid cycle and aerobic respiration. Additionally, mitochondrial 
ribosomes, tRNAs and mitochondrial DNA (mtDNA) are present in the matrix 
as well (Molecular Biology of the Cell, 2011). 
 
While the conversion of energy is the most crucial function of mitochondria, they 
also play vital roles in the metabolism of amino acids (Costa-Guda et al., 2007), 
heme synthesis (major functional form of iron, Lange et al., 1999), or calcium 
homeostasis (Vandecasteele et al., 2001). Mitochondria also mediate apoptotic 
cell death (Fransson et al., 2003), synthesize hormones (Miller et al., 2013) or 
detoxify ammonia by conversion to urea (Norenberg 2003). Dysfunction of 
mitochondria and the associated diseases can directly result from mutations or 
damage to the mitochondrial genes or nuclear proteins, that translocate to the 
mitochondria, which makes the mitochondrial genome maintenance yet another 
crucial function (Prakash et al., 2015). 
Figure 2: Schematic representation of oxidative phosphorylation. Oxidative 
phosphorylation is a metabolic pathway in cells to oxidize nutrients and convert energy in the 
form of ATP. The respiratory chain consists of complexes I–IV. Complex I (NADH coenzyme Q 
oxidoreductase) oxidizes NADH with the reduction of coenzyme Q10 (or CoQ) from its 
ubiquinone (CoQ; Q) form to ubiquinol (QH2), generating an electrochemical gradient across the 
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inner mitochondrial membrane. Complex II (succinate–CoQ oxidoreductase) is linked to the 
Krebs cycle (or tricarboxylic acid (TCA) cycle) within the respiratory chain and oxidizes 
succinate with the reduction of CoQ from its ubiquinone form to ubiquinol. Complex III 
(ubiquinol–cytochrome c oxidoreductase) catalyses the reduction of cytochrome c by oxidation of 
ubiquinol, which generates an electrochemical gradient. Complex IV (cytochrome c oxidase) 
catalyses the terminal reaction of the respiratory chain by transferring electrons (e-) to 
molecular oxygen, further building up the electrochemical gradient. Complex V (ATP synthase) 
converts the transmembrane electrochemical proton (H+) gradient energy into mechanical 
energy, which catalyses ADP and phosphate (P) into ATP (figure adapted from Gorman et al., 
2016). 
 
1.2 Mitochondrial genome maintenance 
In 1963, Margit and Sylvan Nass discovered for the first time the presence of 
DNA within mitochondria through electron microscope imaging of chicken 
embryos (Nass and Nass, 1963). Human mtDNA forms a circular double-
stranded molecule of 16,569 bp size (Figure 3). Its 37 genes encode 13 
polypeptides, 22 transfer RNAs (tRNAs) and 2 ribosomal RNAs (rRNAs), 
necessary for proper assembly and function of the mitochondrial oxidative 
phosphorylation complexes (Anderson et al. 1981). In contrast to diploid nuclear 
DNA (nDNA), a cell contains several hundred to several thousand copies 
mtDNA (Miller et al., 2003, Copeland et al. 2014), residing in the mitochondrial 
matrix. The multiple mtDNA molecules are organized together into protein-
DNA complexes, called nucleoids (Bogenhagen et al., 2008). These histone-free 
formations have a diameter of only ~100 nm (Gilkerson et al., 2013), much 
smaller compared to the contour length of a completely relaxed and circular 
mtDNA molecule with a length of   ~5 µm (Zsurka et al., 2018). A key protein in 
mtDNA nucleoid formation is the mitochondrial transcription factor A (TFAM). 
TFAM contains two high-mobility-group (HMG) domains, which bind to the 
mtDNA and unwind DNA in a non-sequence specific manner (Fisher et al., 
1992).  
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Figure 3: Map of the human mitochondrial genome. Outer and inner circles represent 
heavy (H) and light (L) strands, respectively. Non-coding region (NCR, magnification shown 
above) contains H- and L-strand promoters (HSP, LSP), 3 conserved sequence boxes (CSB1–3), 
the H-strand origin of replication (oriH) and a termination-associated sequence (TAS) - where 
replication from oriH often preterminates, leaving the nascent strand (7S DNA) bound to the 
template strand, creating a displacement loop (D-loop). Genes encoded on the H-strand 
(clockwise direction): cytochrome b (Cyt b), complex III; NADH dehydrogenase (ND), complex I; 
cytochrome c oxidase (COX), complex IV; ATP synthase (ATPase), complex V; ribosomal RNA 
(rRNA). L-strand-encoded genes: NADH dehydrogenase (ND). Black boxes on both strands 
indicate transfer RNA (tRNA) genes (Figure adapted from Uhler et al., 2015). 
 
The mtDNA strand with higher content of guanine bases is called heavy (H) 
strand; its complementary strand, rich in cytosine bases, light (L) strand (Davis 
and Clayton, 1996). The origins of replication are termed oriH and oriL for each 
strand, respectively. Replication of mtDNA for the H-strand is initiated in a non-
coding region (NCR), but partly stops at a termination-associated sequence 
(TAS), leaving a short nascent strand (7S DNA) bound to the light strand, which 
creates a displacement loop (D-loop, Cairns and Bogenhagen, 1986; Brown et 
al., 1986, Fish et al., 2004). This D-loop covers most, but not all of the NCR. 
Besides oriH, the NCR also contains promoters for transcription of the heavy- 
and light-strand (HSP and LSP), respectively (Nicholls et al., 2014). The role of 
7S DNA is still unclear. Different hypotheses have been made over the years, 
suggesting that 7S DNA acts as a primer for H-strand replication or it is an 
aborted product of nascent H-strand synthesis (Nicholls et al., 2014).  
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It was also proposed that the D-loop serves as a binding centre of proteins, 
involved in the regulation of mitochondrial nucleoids (He et al., 2007). 
 
1.3 Replication of mtDNA 
In the late 60’s, screening of rat liver mitochondria revealed replication circles 
of DNA (Leffler II et al., 1970), together with a newly discovered mitochondrial 
DNA polymerase (Meyer and Simpson, 1968), which differs from the nuclear 
polymerase. This proved independent mtDNA replication within the 
mitochondrion. Since then, hypotheses about mtDNA replication have 
constantly evolved and been discussed. 
 
1.3.1 Strand-displacement model 
The strand-displacement model (SDM), or asynchronous replication model, was 
the first proposed model for mtDNA replication, described by Robberson et al. in 
1972. It describes an asymmetric mechanism of mtDNA replication, starting 
from the oriH in clockwise direction, further expanding the D-loop and 
progressing towards the oriL (Figure 4). Once oriL is reached, it is exposed and 
H-strand replication stalls, while synthesis of the lagging strand proceeds in the 
opposite direction. After L-strand replication started, leading strand synthesis 
continues forth. By the time when replication of the H-strand is complete, L-
strand synthesis has only finished two-third of its replication, spanning over the 
major arc from oriL to oriH with an approximate length of 11 kilobases (kb). 
This so called gapped circle molecule, stemming from the displaced strand, 
continues replication anti-clockwise until it reaches oriL and finishes L-strand 
replication (Clayton et al. 1982). 
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Figure 4: Asymmetric strand-displacement model of mtDNA replication. Replication of 
H-strand initiated at oriH, leads to further expansion and displacement of the D-loop. Once the 
oriL is exposed on the L-strand, the replication continues, followed by synthesis of new L-strand 
in the opposite direction. Intermediates of both strands are formed. The asymmetric replication 
creates one complete and one gapped circle (GpC) mtDNA molecule (Figure adapted from Brown 
et al., 2005). 
 
1.3.2 Strand-coupled replication model 
In 2000, Holt and colleagues questioned the strand-displacement model, after 
electron microscopy of mtDNA from rat hepatocytes and HeLa cells revealed 
duplex replication intermediates (Koike and Wolstenholme, 1974, Crews et al., 
1979) and raised the hypothesis for coupled leading and lagging strand 
replication. The new model by Holt et al. described a symmetrical or strand-
coupled replication of leading and lagging strand synthesis (Holt et al., 2000), 
progressing from bidirectional replication forks (Figure 5). Followed by the 
experimental results by Yang et al. in 2002, replication would involve mostly 
double-stranded replication intermediates, with multiple RNA–DNA hybrids 
present on the light strand. These hybrids were then cleaved by RNase H1, 
resulting in single-stranded DNA intermediates. Replication, according to this 
model would create two complete daughter molecules at same pace, with no 
gapped circle molecule. 
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Figure 5: Strand-coupled model of mtDNA replication. Synchronous replication is 
initiated within a broad area beyond the simple D-loop. The double-stranded replication forks 
synthesize both strands bidirectionally and proceed through the length of the mtDNA, 
preventing the formation of oriL strand intermediates and the formation of gapped circle 
molecules (Figure adapted from Brown et al., 2005). 
 
In 2005, Brown et al. presented atomic force microscopy (AFM) results from 
mouse liver, that questioned the strand-coupled replication model and 
supported the orthodox, strand-displacement model. However, they claimed the 
existence of more than one light strand replication origin, which would require 
further modifications on the strand-displacement model, currently holding only 
one oriL. Together with previous findings from the literature (Robberson et al., 
1972; Koike and Wolstenhole, 1974; Pikó et al., 1984), they all favour the 
asynchronous replication model.  
 
1.3.3 RITOLS replication model 
After the results from Brown et al. questioned the strand-coupled replication 
model, but also indicated missing pieces of evidence on the strand-displacement 
model, Yasukawa et al. proposed new findings one year later, regarding the 
properties of these replication intermediates, using two-dimensional gel 
electrophoresis (2D-AGE, Yasukawa et al., 2006). They presented a novel 
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replication model, termed ribonucleotide incorporation throughout the lagging 
strand (RITOLS). Their investigation on the presumed intermediates of strand-
coupled synthesis showed the formation of duplex intermediates, created from 
slow-moving arcs of replication (Figure 6). These intermediates were 
indistinguishable from duplex DNA based on their mass and shape, however no 
restriction endonuclease, targeting double-stranded DNA (dsDNA) was able to 
cut them. Treatment with RNase H1, proved highly effective (which degrades 
RNA only if it is hybridized to DNA) and resulted in the formation of single-
stranded DNA. Further 2D gel analysis on extracted mitochondrial replication 
intermediates (mtRIs) revealed L-strand RNAs of 200–600 nucleotides in 
length. Yasuka et al. therefore suggested, that RNA was incorporated 
throughout the lagging strand during mtDNA replication (Yasuka et al. 2006). 
The RITOLS model of replication resembles the SDM quite well: both models 
predict asynchronous mtDNA synthesis and mark the oriL as a major initiation 
site of light-strand synthesis. The NCR is also regarded as the oriH-containing 
region in both, however the RITOLS model proposes two origins (OR) within the 
D-loop, one close to each end (Yasukawa et al., 2006). To put it simple, RITOLS 
replication equal SDM plus lagging strand RNA incorporation (Holt and Reyes, 
2012). In 2013, Holt and colleagues argued that during leading strand synthesis, 
pre-existing RNA is incorporated into the lagging strand via a “bootlace” 
strategy and not being synthesized in parallel (or symmetrical) to leading strand 
synthesis (Reyes et al., 2013). 
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Figure 6: RITOLS model of mtDNA replication. 1) Incorporation of RNA (red) throughout 
the lagging strand with DNA (blue) synthesis on the leading strand. As the fork advances 
preformed RNA is threaded through the replication complex in 3’–5’ direction, hybridized to the 
displaced parental strand 2) Bootlace model. Unidirectional replication initiated at one of two 
origin(s) of RITOLS (OR) within the NCR. Lagging strand is initially laid down as RNA. As the 
replication fork advances, conversion to DNA starts a) after the entire lagging strand is fully 
incorporated as RNA b) at the oriL(OL) or c) at scattered sites around the genome. (Figure 
adapted from Yasukawa et al., 2006).  
 
 
1.4 Members of the mtDNA replisome 
The core members of the mitochondrial replication machinery include the 
mitochondrial homohexamer helicase Twinkle (TWNK), the mitochondrial DNA 
heterotrimer enzyme polymerase gamma (POL γ), the mitochondrial single-
stranded DNA-binding protein (mtSSB) and the mitochondrial RNA polymerase 
(POLRMT, Figure 7). In 2004, a minimal mtDNA replisome was rebuilt in vitro, 
containing a dsDNA template and recombinant forms of the human TWNK, 
POL γ and mtSSB (Korhonen et al., 2004).  
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Figure 7: The mtDNA replication machinery. Replication model, showing two replication 
forks. Twinkle helicase (blue) unwinds dsDNA (black lines) in 5’–3’ direction. mtSSB (dark 
green) stabilizes the ssDNA (black line) and stimulates DNA synthesis (red line) by POL γ 
(catalytic subunit A: red, accessory subunits B: gray). POLRMT (light green) synthesises RNA 
primer (yellow line) for lagging strand DNA synthesis (Figure adapted from Wanrooij and 
Falkenberg, 2010). 
 
 
POL γ and TWNK alone were able to assemble on the dsDNA template with 
preformed replication forks to synthesize single-stranded DNA (ssDNA) 
products of ~2 kb. With the addition of mtSSB, the processivity of the replication 
machinery drastically increased and generated DNA products longer than 16 kb 
– the size of the human mitochondrial genome (Korhonen et al., 2004). 
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Based on the reconstructed minimal replication machinery and together with 
recent findings, additional factors were incorporated into the hypothesis on 
mtDNA replication and proposed a novel replication model (Figure 8) and 
included additional enzymes, like the mitochondrial genome maintenance 
exonuclease 1 (MGME1), mitochondrial ligase III (mtLigIII) and mitochondrial 
transcription factor A and B2 (TFAM and TFB2M). TFAM and TFB2M both 
interact with POLRMT during RNA primer synthesis. MGME1 degrades ssDNA 
in 5’–3’ direction, unwound by Twinkle and mtLigIII seals the mtDNA nicks 
(DeBalsi et al., 2017). 
Figure 8: Schematic diagram of the updated mtDNA replication machinery. POLRMT 
produces RNA primer (jagged red line), required to initiate DNA replication in conjunction with 
TFAM (deep blue) and TFB2M (gray). After initiation, POLRMT, TFAM and TFB2M separately 
leave the DNA and the RNA primer is degraded by RNase H1 (yellow). In a 5’–3’ direction, 
Twinkle helicase (pink) unwinds dsDNA at the replication fork. The ssDNA is stabilized by 
mtSSB (light blue), while MGME1 (red) degrades ssDNA. MtLigIII (white) seals the mtDNA 
nick. Nascent DNA (solid red line) is synthesized by Pol γ (green). Topoisomerases (brown) 
relieve the torsional tension in the DNA, caused by unwinding (Figure adapted from DeBalsi et 
al., 2017). 
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1.4.1 Mitochondrial helicase Twinkle 
In 2001, Spelbrink et al. described for the first time the mitochondrial helicase 
Twinkle. It showed a high similarity to the T7 bacteriophage primase/helicase 
(gene 4 protein, gp4), which gave rise to its name (T7 gp4-like protein with 
intramitochondrial nucleoid localization). In vitro, Twinkle forms multimers, 
with a hexameric ring helicase as the functional enzyme (Spelbrink et al., 2001), 
that unwinds short stretches (<20 bp) of dsDNA in 5’–3’ direction (Korhonen et 
al., 2004). Within the mitochondrial replisome, Twinkle needs free DNA ends, 
that can be threaded through the helicase ring in order to execute its enzymatic 
activity.  
 
1.4.2 Mitochondrial polymerase gamma 
In humans, POL γ is the only known DNA polymerase involved in mtDNA 
synthesis (Ropp and Copeland, 1996). It is an asymmetric holoenzyme (or 
heterotrimer; 245 kDa) built of one catalytic subunit POLG (140 kDa) and two 
accessory subunits of POLG2 (53 kDa) (Carrodeguas et al., 2001; Yakubovskaya 
et al., 2006). The POLG subunit has a 5’–3’ polymerase activity, a 3’–5’ 
exonuclease proofreading activity and a 5’-deoxyribose phosphate (dRP) lyase 
activity, used for base excision repair (Foury and Vanderstraeten, 1992). 
Subunit POLG2 accelerates the polymerization rate by enhancing the affinity 
for DNA of the catalytic subunit. It prefers binding to dsDNA and could provide 
proper binding of POLG to the template strand behind the slower moving 
Twinkle helicase and helps in coordinating enzymatic activities of TWNK and 
POLG at the mtDNA replication fork (Wanrooij and Falkenberg, 2010). 
 
1.4.3 Mitochondrial single-strand binding protein (mtSSB) 
The mtSSB forms a tetramer (13–15 kDa) that binds ssDNA (Thömmes et al., 
1996), preventing it from refolding or being degraded by nucleases. The ssDNA 
wraps around the tetramer in electropositive channels, guided by flexible loops 
(Yang et al., 1997). Together with TFAM, mtSSB is suggested to influence the 
stabilization as well as the turnover of the D-loop (Takamatsu et al., 2002). 
MtSSB has been shown to improve primer recognition and binding by POL γ 
(Farr et al., 1999) in the mitochondrial replisome. 
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1.4.4 Mitochondrial RNA polymerase and primase (POLRMT) 
Mitochondrial transcription relies on a unique RNA polymerase (Greenleaf et 
al., 1986). Transcription is initiated at the light-strand promoter (LSP) within 
the NCR (Falkenberg et al., 2002), but POLRMT requires two additional 
transcription factors: TFAM and TFB2M (Asin-Cayuela et al., 2007). In the 
mitochondrial replisome, POLRMT synthesizes RNA primers, used to initiate 
leading-strand mtDNA synthesis at the oriH, that can be utilized by POL γ to 
initiate DNA replication (Wanrooij and Falkenberg, 2010). But POLRMT also 
specifically synthesizes RNA primers of ~25 nucleotides at the oriL in the 
presence of mtSSB, for lagging strand synthesis (Fuste et al., 2010). 
 
1.4.5 Mitochondrial genome maintenance exonuclease1 (MGME1) 
MGME1 is an exonuclease that localizes in mitochondria and belongs to the PD-
(D/E)XK nuclease superfamily. It requires free nucleic acid ends for catalysis 
and processes 5’-flaps during mtDNA replication. MGME1 also possesses 3’–5’ 
exonuclease activity on ssDNA (Kornblum et al., 2013; Nicholls et al., 2014) and 
is involved in mtDNA maintenance.   
 
1.5 Mitochondrial DNA damage and repair pathways 
Damaged mtDNA can arise, like nDNA, from DNA polymerase replication 
errors, DNA strand breaks, or through exposure to radiation, genotoxic 
chemicals or reactive oxygen species (ROS, Alexeyev et al., 2013). During 
oxidative phosphorylation, the partial reduction of oxygen constantly challenges 
mtDNA to ROS exposure (Lenaz, 2001), given the natural proximity of ROS 
production sites and the nucleoids within the mitochondrial matrix (Wiesner et 
al., 2006). Oxidative damage caused by ROS includes single-strand DNA breaks 
(SSB) and double-strand DNA breaks (DSB). Mutations of mtDNA through ROS 
exposure comprise base substitution, deletions and missense mutations (Cline, 
2012). SSBs usually result in the loss of a single nucleotide and damaged 5’ 
and/or 3’ ends at the breakage.  
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1.5.1 Base excision repair (BER) 
Apart from oxidative damage, SSBs can also occur during base excision repair 
(BER), by enzymatic cleavage of the phosphodiester backbone (Alexeyev et al., 
2013). Mitochondrial BER is initiated by DNA glycosylases (Prakash et al., 
2015), which recognize and cleave oxidized or damaged bases either by a single-
nucleotide-BER (SN-BER) or long-patch-BER (LP-BER) pathway (Figure 9). 
Both of these single-strand break repair (SSBR) pathways leave an abasic site, 
that is cleaved at a 5’-end by an apurinic/apyrimidinic (AP) endonuclease (APE 
or APEX), generating a gap, which is filled up by POL γ to a 5’-deoxyribose 
phosphate (dRP) flap (or 5’-flap, Hedge et al., 2012; Copeland et al., 2014). 
In mitochondrial SN-BER, POL γ filled in a single nucleotide to create a 
ligatable substrate, that requires the removal of the 5’-dRP fragment, which is 
performed by the catalytic subunit of POL γ (Longley et al., 1998). In the LP-
BER pathway, the displaced 5’-flaps must also be removed prior ligation, but is 
assumed to be performed by DNA replication helicase/nuclease 2 (DNA2, 
Masuda-Sasa et al., 2006) or Flap structure-specific endonuclease 1 (FEN-1, 
Hiraoka et al., 1995), but might also be performed by Mitochondrial Genome 
Maintenance Exonuclease 1 (MGME1, Kornblum et al., 2013) or 
Exo/Endonuclease G (EXOG, Tann et al., 2011) under certain circumstances. 
DSB either result in the formation of blunt ends or, 5’ or 3’ overhangs. DSB 
repair (DSBR) is performed by homologous recombination (HR), also known as 
homologous directed repair (HDR), or nonhomologous end joining (NHEJ, 
Alexeyev et al., 2013).  
In HR, a single strand of the damaged DNA invades a healthy complementary 
strand, leading to a D-loop formation and subsequent DNA synthesis. In order 
to anneal properly, long stretches of homology are required. Afterwards, the 
damaged strand reanneals with its own complementary strand, the gap is filled 
in and ligation eventually repairs the dsDNA.  Standard NHEJ is supposed to 
be absent in mtDNA repair and is instead replaced by microholomogy-mediated 
end-joining (MMEJ, Tadi et al., 2015), as supportive studies showed that ~85 % 
of mtDNA deletions were flanked only by short repetitive sequences (Krishnan 
et al., 2008). 
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Figure 9: MtDNA base excision repair pathways in mammalian mitochondria. An 
oxidized base is excised by a glycosylase, leaving an abasic site. APE1 creates a SSB with a 5’-
dRP flap on the downstream DNA. Single-nucleotide-BER (SN-BER) repair pathway involves 
POL γ filling the single nucleotide gap and removing the 5’ deoxyribose phosphate (dRP) flap, 
creating a ligatable substrate. In LP-BER, the extended 5’-dRP flap is recognized and cleaved 
by MGME1 and FEN1, prior to ligation by ligase III. Alternately, the 5’ end may be processed 
by DNA2 or EXOG to produce a ligatable substrate (figure adapted from Copeland and Longley, 
2014). 
 
Mitochondrial HR is still questioned, as various experiments showed either no 
recombination, even under selective environmental pressure (Gilkerson et al., 
2008), or only low amounts of intermolecular recombination after mtDNA 
depletion (D’Aurelio et al., 2004) or induced DSB (Bacman et al., 2009).  
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1.5.2 Nucleotide excision repair (NER) 
In 1975, Clayton et al. demonstrated proof for the absence of a pyrimidine dimer 
repair mechanism for mtDNA in mice and humans. Alkylation damage to 
mtDNA or UV-exposure-caused mutations were also unable to be repaired by 
NER in mitochondria (Pascucci et al., 1997; Croteau and Bohr, 1999; Copeland 
and Longley, 2014). 
 
1.5.3 Mismatch repair (MMR) 
The mismatch repair pathway in nuclear DNA can remove base mismatches, 
short insertions or deletions (Copeland et al., 2014). In mitochondria, the 
presence of MMR pathways was reported in Saccaromyces cerevisiae (Alani et 
al., 1994), but not in higher eukaryotes (Copeland et al., 2014). 
 
1.5.4 Ribonucleotide excision repair (RER) 
Human cells contain two RNase H enzymes, that remove incorporated RNA 
(Sparks et al., 2012) during a process, called RER. RNase H1, as mentioned 
before, cleaves and degrades RNA from RNA–DNA hybrids, while RNase H2 
removes individually incorporated ribonucleotide 5’-monophosphate (rNMP) 
residues in DNA (Copeland et al., 2014). However, only RNase H1 is present in 
mitochondria (Cerritelli et al., 2003). The single ribonucleotides in the template 
DNA can be bypassed by POL γ, which has a strong reverse transcriptase 
activity (Copeland et al., 2014). 
 
1.6 Mitochondrial nucleases and mtDNA degradation 
Due to the multicopy nature of the mitochondrial genome, mtDNA is not 
constrained to “repair or die” compared to diploid nDNA. A fraction of mtDNA 
can be lost without damaging effects (Alexeyev et al., 2013), which leads to a 
different handling of damaged mtDNA, that cannot be repaired–namely through 
degradation. This degradation of damaged mtDNA is suggested to be performed 
by nucleases (Bruni et al., 2016), yet the complete degradation machinery, or 
‘degradosome’ of mtDNA is still unknown.  
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Up to date, there are several identified mitochondrial DNases (Table 1) with 
endonuclease or strand-specific exonuclease activity (Bruni et al., 2016) that 
might influence mtDNA degradation.  
 
Table 1: Mitochondrial DNases (table adapted from Bruni et al., 2016). 
Nuclease Mitochondrial 
process(es) 
Cleavage activity Substrate 
DNA     RNA 
APEX1 Base excision repair Endonuclease +  
APEX2 Base excision repair Endonuclease +  
  ssDNA 3’–5’ Exonuclease   
FEN1 Base excision repair 5’–3’ Exonuclease + + 
 Flap processing 5’-flap Endonuclease   
  RNase H activity   
DNA2 Flap processing Endonuclease +  
MGME1 Flap processing ssDNA 5’–3’ Exonuclease +  
 Base excision repair ssDNA 3’–5’ Exonuclease   
MRE11 DSB repair Endonuclease +  
  ssDNA 3’–5’ Exonuclease   
RBBP8 DSB repair Endonuclease +  
ENDOG Apoptosis Endonuclease + + 
EXOG SSB repair 5’–3’ Exonuclease + + 
  Endonuclease   
 
As mentioned earlier, APEX1 generates a gap at apurinic/apyrimidinic sites 
during BER, that forms a 3’ end with a hydroxyl group used to initiate DNA 
replication and a 5’ phosphate residue, which must be removed to fully ligate 
the replicated DNA. APEX2 localizes predominantly in the nucleus, but also to 
some extend in mitochondria (Tsuchimoto et al., 2001). It is presumed to be 
involved in nuclear BER; activity in mitochondria has not been demonstrated 
yet (Bruni et al., 2016). APEX2 also possesses a 3’–5’ exonuclease activity, 
preferentially targeting mismatched base pairs (Burkovics et al., 2006), that 
could potentially be utilized in degradation of linear mtDNA. 
Interactions between FEN1 and DNA2 have shown an increased flap processing 
efficiency (Zheng et al., 2008), yet mitochondrial localization of FEN1 is still 
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questioned (Bruni et al., 2016). MGME1 is involved in mtDNA maintenance and 
processes 5’-flaps during mtDNA replication, but also possesses 3’–5’ 
exonuclease activity on ssDNA (Kornblum et al., 2013; Nicholls et al., 2014). 
MRE11 exerts DNA endonuclease and 3’–5’ exonuclease activity and forms the 
MRN complex with the RAD50 homolog and NBS1 (or Nibrin), required for 
NHEJ (Buis et al., 2008). Together with the endonuclease RBBP8 (or 
Retinoblastoma-binding protein 8, also known as CtBP-interacting protein, 
CtIP), the MRN complex can also perform DSB repair through the HR pathway 
(Chen et al., 2008). EXOG possesses endonuclease nicking activity on 
supercoiled DNA and also favours ssDNA for its 5’–3’ exonuclease activity 
during SSB repair (Cymerman et al., 2008).  
 
1.7 Mitochondrial diseases 
Since mtDNA is limited by its DNA repair capacity (Young et al., 2016), it is 
more prone to damage than nDNA with an estimated 10–20 times higher 
mutation rate (Richter et al., 1988). Accumulated mutated mtDNA leads to 
phenotypic manifestations in mitochondria if a certain threshold is exceeded 
(Rossignol et al., 2003). Since disease-associated mutations of mtDNA are often 
heteroplasmic (they exist simultaneously with wildtype mtDNA and do not 
occur in every copy of mtDNA in each cell), the proportion of wild-type vs. 
mutated mtDNA determines the pathological nature of mitochondrial disease, 
depending on the affected organ (Figure 10) and age of onset (Debrosse and 
Parikh, 2012). 
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Figure 10: Clinical representations of mitochondrial diseases. Onset of mitochondrial 
diseases highly variates between patients and can encompass dysfunction of any organ or tissue, 
but can be divided in two characteristics: neurological or non-neurological (figure adapted from 
Gorman et al., 2016). 
 
Pathogenic mtDNA mutations affect the structural subunits of the respiratory 
chain (through mtDNA rearrangements/deletions) or the mitochondrial protein 
synthesis machinery (through mutations in mRNA, rRNA, tRNA; Gorman et al., 
2016). Over 200 disorders are associated with point mutations or single 
deletions in mtDNA (Chabi et al., 2003). The largest subset includes functional 
mutations of the respiratory chain, occurring at least once in 5000 live births 
(Vafai and Mootha, 2012). Assessing the prevalence of mtDNA mutations is still 
difficult, because molecular screening usually restricts to detection of mtDNA 
deletions (plus a few common mutations, Bannwarth et al., 2013). Only whole 
mtDNA screenings can reliably reveal rare mtDNA mutations.  
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1.7.1 MtDNA maintenance disorders 
There are three major classes of pathological mtDNA alterations: point 
mutations, deletion-duplications and reduced mtDNA copy numbers. For the 
latter, a copy number reduction below 30% of the normal mtDNA content is 
defined as mtDNA depletion and usually results in lethal infancy or childhood 
diseases due to deficiencies in the mtDNA encoded proteins of respiratory chain 
complexes I, III, IV and V (Rötig and Poulton, 2009). 
Errors or inaccuracies in mtDNA maintenance can also result in deletion of 
mtDNA. The majority of mtDNA deletions was found in close vicinity of direct 
repeats (DR, Bua et al., 2006) but also near stem-loops (SL, Lakshmanan et al., 
2012). Mechanisms, that can lead to the formation of deletions between DRs 
include DSB repair (Krishnan et al., 2008) and slip-replication (Shoffner et al., 
1989). The slipped-strand mechanism (Figure 11) assumes the asynchronous 
strand displacement model and describes misannealing of a single-stranded 
repeat of the H-strand during replication with a newly synthesized L-strand 
repeat (Pitceathly et al., 2012). A loop of the single-stranded H-strand forms and 
it eventually gets degraded, while the free ends ligate and allow continued 
replication. The deleted loop however, results in a mtDNA major arc deletion 
(Krishnan et al., 2008). 
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Figure 11: Slipped-strand model of mtDNA deletion formation. A) MtDNA molecule prior 
replication, containing two direct homologous repeats (a/a1 and b/b1) with origins of replication 
(OH - heavy, OL - light) shown. B) MtDNA replication initiated at OH. The newly formed 
daughter heavy strand (brown) uses L-strand as template, thereby displacing the parental H-
strand. C) Two direct homologous repeats between parental H-strand and L-strand (a and b1) 
misanneal, forming a downstream H-strand loop. The free ends of the parental H-strand are 
ligated and replication of the daughter H-strand continues. D) Slipped strand replication results 
in the synthesis of two mtDNA molecules, one wild-type (parent L-strand plus daughter H-
strand) and one deleted (parent H-strand and daughter L-strand) molecule (Figure adapted from 
Pitceathly et al., 2012). 
 
Krishnan et al. suggested that not the slipped-strand mechanism, but DSB 
repair is the responsible major cause for the formation of large scale deletions 
(Figure 12). After DSB, the free mtDNA ends are susceptible to exonuclease 
activity, resulting in the formation of single-strand ends. The homologous 
repeats within both strands misanneal, in which the overhangs get degraded, 
resulting in the formation of a partially deleted mtDNA molecule. Besides 
homologous-directed end joining repair of DSB, NHEJ repair of DSB can also 
result in the formation of deletions, even in the absence of direct repeats 
(Gredilla et al., 2012). 
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Figure 12: Model for the generation of mtDNA deletions during DSB repair. A) wild-
type mtDNA molecule, with two indicated direct repeats (3’ and 5’). B) Introduced DSB. C, D) 
DSB is susceptible to 3’–5’ exonuclease activity, resulting in the formation of single-stranded 
ends. E) The direct repeats can misanneal, resulting to degradation of the unbound single-
stranded ends and ligation of double strand. F) A partially deleted mtDNA molecule forms, with 
copies of 5’ and 3’ repeats. If the repeats contain mismatched bases, subsequent repair could use 
either strand as a template to correct the mismatch (Figure adapted from Krishnan et al., 2008).  
 
1.7.2 Disease-associated mtDNA alterations 
Through aging, mtDNA maintenance disorders or neurodegenerative diseases, 
the heteroplasmic drift of mtDNA mutations can extend to the entire cell, 
through a process called clonal expansion. Clonal expansion of large-scale 
mtDNA deletions or mtDNA copy number reduction (depletion) can lead to 
prominent clinical phenotypes. The most frequent presentations (Table 1.1) 
include autosomal dominant chronic progressive external ophthalmoplegia 
(adCPEO), mitochondrial neurogastrointestinal encephalomyopathy (MNGIE), 
hepatopathic poliodystrophy (Alpers–Huttenlocher syndrome), seonsory-ataxia 
neuropathy, dysarthria and ophthalmoplegia (SANDO), infantile-onset 
spinocerebellar ataxia (IOSCA) and spinocerebellar ataxia and epilepsy (SCAE, 
Viscomi and Zeviani, 2017). 
 
 
 
A B C 
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Table 1.1: Genes and phenotypes in altered mtDNA maintenance (Table adapted from 
Viscomi and Zeviani, 2017). 
 
Gene mtDNA alteration Inheritance* Main clinical phenotype 
TWNK Multiple deletions AD adCPEO 
 Multiple deletions AR IOSCA 
 Depletion AR Alpers-like 
POLG Multiple deletions AD adCPEO 
 Multiple deletions AR adCPEO 
 Depletion AR Alpers-Huttenlocher 
 Multiple deletions AR SANDO/SCAE 
POLG2 Multiple deletions AD adCPEO 
MGME1 Multiple deletions AR adCPEO 
DNA2 Multiple deletions AD adCPEO 
TFAM Depletion AR Hepatocerebral syndrome 
TYMP Multiple deletions 
and depletion 
AR MNGIE 
*AD = autosomal dominant; AR = autosomal recessive 
 
1.8 CRISPR/Cas9 genome-editing and mitochondria 
Studying mtDNA maintenance can be performed by various approaches, like 
directly modelling mtDNA damage, or by manipulating components of the 
mtDNA maintenance machinery. Modern gene-editing in living cells has become 
cost-efficient, fast and easy to handle, due to the CRISPR/Cas9 genome-editing 
system. Compared to restriction endonucleases, the CRISPR/Cas9 tool allows 
precise targeting of specific genes to introduce DSB followed either by NHEJ or, 
in case of a repair template, HR. Direct mitochondrial genome engineering is 
still elusive, as the existence of an endogenous mechanism for nucleic acid 
import into mammalian mitochondria, which is a prerequisite for mitochondrial 
CRISPR/Cas9-editing, remains controversial (Gammage et al., 2017). Therefore, 
genetic engineering, by CRISPR/Cas9 can only be performed on nuclear genes, 
which encode mitochondrial proteins. 
 
 
Introduction 
33 
 
CRISPR stands for Clustered Regularly Interspaced Short Palindromic 
Repeats and was coined in 2002 by Jansen et al. to describe repetitive repeats 
in bacterial and archaeal genomes. CRISPR-associated (Cas) genes are located 
near a CRISPR locus and indicate functional relationship. Cas3 genes possess 
characteristics of helicases of the superfamily 2 and Cas4 genes show motifs of 
the RecB family of exonucleases, which suggests the involvement of these genes 
in DNA metabolism or gene expression (Jansen et al., 2002). Over the next years 
CRISPR research identified CRISPR spacer sequences matching foreign DNA 
(Bolotin et al., 2005) and CRISPR was characterized as a bacterial adaptive 
immune system (Makarova et al., 2006). In 2010, the CRISPR/Cas system was 
identified as a bacterial and archaeal immune system, that targets and cleaves 
phage DNA, that can also insert new spacer sequences into the genome, making 
the CRISPR/Cas system an adaptive immune system (Garneau et al., 2010). One 
year later, Cas9 from Streptococcus pyogenes was described to associate with 
two RNA molecules: CRISPR RNA (crRNA) and trans-activating CRISPR RNA 
(tracrRNA). These three components together were sufficient to protect S. 
pyogenes against phage infection (Deltcheva et al., 2011). Following these 
discoveries, in 2012 Cas9 was described as an endonuclease, introducing DSB 
in DNA, allowing complementary binding of crRNA to the target DNA (Jinek et 
al., 2012). Finally, in 2013, the CRISPR/Cas9 system was used to edit targeted 
genes in both human and mouse cells, using custom made crRNA sequences 
(Cong et al., 2013). The technique was further improved in 2014, through the 
identification of protospacer adjacent motifs (PAM), which are required for the 
RNA-guided DNA recognition (Anders et al., 2014) and the design of a single 
guide RNA (sgRNA), combining the functions of crRNA and tracrRNA 
(Nishimasu et al., 2014; Ramakrishna et al., 2014). Today CRISPR/Cas9 
encoding plasmids are commercially available and can target any nuclear gene 
of interest, given an adjacent PAM sequence (Figure 13). 
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Figure 13: Schematic representation of CRISPR/Cas9-mediated genome editing. A) 
Schematic CRISPR locus (from Streptococcus pyogenes). B) Site-specific DNA cleavage by Cas9 
nuclease, directed by complementary single guide RNA (sgRNA), complementary to target site, 
given a protospacer-adjacent motif (PAM) on the opposite strand. C) The resulting double-strand 
break (DSB) and subsequent repair, either by non-homologous end joining (NHEJ) or homology-
directed repair (HDR), in presence of a donor template. NHEJ is more error prone to produce 
indels, whereas HDR can result in precise gene modification. (figure adapted from Dai et al., 
2016 (a & c); Integrated DNA technologies (eu.idtdna.com), 02.2018 (b)).
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1.9 Aims 
 
The main focus of this thesis was dedicated to the study of the role of 
mitochondrial nucleases in degradation of linear mtDNA, to gain insights into 
the still unknown mtDNA degradation machinery. For this purpose, I used the 
CRISPR/Cas9 genome-editing tool to alter mitochondrial nucleases in living 
cells. (I) In the first step, I had to design and assemble custom-built 
CRSIRP/Cas9-vectors against gene-specific target sequences. Once applied, 
cloning strategies had to be established and optimized to handle the ample 
screening process, in order to identify positive clones, bearing the altered 
mitochondrial nucleases. A HEK 293 T-REx cell line was used, expressing the 
mitochondrial-targeted endonuclease protein EagI, as a model of mtDNA 
damage by introducing DSB’s and linearization of mtDNA. Once the individual 
cell lines were identified through screening, bearing the desired mutations for 
the targeted genes, mitoEagI expression had to be checked for its endonuclease 
activity to excluded potential off-target effects by CRISPR/Cas9. (II) In the next 
step, I used the validated mitoEagI mutant cell lines to induce mitoEagI 
expression and study linear mtDNA degradation over the first twenty-four 
hours in two-hour intervals, which allowed me to compare time-dependent 
degradation effects between the mutant clones. Additionally, prolonged 
degradation experiments were performed, together with dideoxycytidine 
treatment instead of mitoEagI induction to linearize mtDNA, to study long-term 
effects of mutant nucleases on mtDNA degradation. Taken together, this study 
aimed to identify key enzymes in the mitochondrial degradation machinery and 
to show their function in removal of linear mtDNA, which would overall give a 
better understanding of mtDNA maintenance. 
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2. Materials & Methods 
Table 2: Chemicals 
Compound     Supplier      
Acrylamide/Bis solution, 40%  BIO-RAD  
Agarose     Sigma-Aldrich 
Ammonium persulfate (APS)  Carl Roth GmbH & Co. KG 
Bromophenol blue    Sigma-Aldrich  
Bovine serum albumin   Sigma-Aldrich  
2’,3’-dideoxycytidine   Sigma-Aldrich 
Coomassie Brilliant Blue R-250  BIO-RAD 
CSPD      Roche 
Digitonin     Serva Electrophoresis GmbH  
dNTPs     Sigma-Aldrich 
DIG Easy Hyb     Sigma-Aldrich 
Dimethyl sulfoxide (DMSO)  Merck  
Dulbeco’s modified eagle’s medium 
(DMEM), GlutaMAX   Thermo Fisher Scientific 
EDTA     Sigma-Aldrich 
Ethidium bromide    Sigma-Aldrich 
Fetal calf serum (FCS)   PAN-Biotech 
Glycerol     Sigma-Aldrich 
Hydrochloric acid (HCL)   Sigma-Aldrich 
Mannitol        Sigma-Aldrich 
MgCl2        Sigma-Aldrich 
Midori Green    Nippon Genetics 
PBS (Phosphate buffer saline) pH 7.4 Invitrogen Corporation 
PBST (PBS with Tween 20)  Thermo Fisher Scientific 
Penicillin / Streptomycin   Invitrogen Corporation 
PicoGreen     Thermo Fisher Scientific 
Saline sodium citrate (SSC)  Thermo Fisher Scientific 
Sodium chloride (NaCl)   Sigma-Aldrich 
Sodium dodecyl sulphate (SDS)  Sigma-Aldrich 
Sodium hydroxide (NaOH)  Sigma-Aldrich 
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SuperSignal West Pico Chemi-  Thermo Fisher Scientific 
luminescent Substrate   
SYBR Green I nucleic acid gel stain  Sigma-Aldrich 
Tetramethylethylendiamin (TEMED) Sigma-Aldrich 
Tris-Borat- EDTA buffer solution  Sigma-Aldrich 
Trizma (TRIS)    Sigma-Aldrich 
Uridine      Sigma-Aldrich 
Xylene cyanol    Merck 
1 kb DNA ladder     New England Biolabs  
1 kb Extended DNA ladder   New England Biolabs 
2-Log DNA ladder (0.1–10.0 kb)  New England Biolabs 
25 bp DNA ladder     Invitrogen Corporation 
DIG-labeled DNA Molecular Weight  
Marker II and III     Roche 
 
Table 3: Antibodies 
Antibody      Supplier     
Anti-beta-Actin antibody    GeneTex 
Anti-DIG fab fragments    Roche 
Anti-HA antibody     Thermo Fisher Scientific 
Secondary anti-rabbit IgG-peroxidase- Sigma-Aldrich 
Conjugated 
 
Table 4: Enzymes 
All enzymes used the provided reaction buffers by the manufacturer.  
Enzyme     Supplier      
ExoSAP-IT PCR Product Cleanup Thermo Fisher Scientific 
JumpStart AccuTaq LA polymerase Sigma-Aldrich 
Mung Bean nuclease   New England Biolabs 
Proteinase K     Qiagen  
Restriction Endonuclease ApaI  New England Biolabs 
Restriction Endonuclease BamHI New England Biolabs 
Restriction Endonuclease EcoRV New England Biolabs 
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Restriction Endonuclease PstI  New England Biolabs 
Restriction Endonuclease SpeI  New England Biolabs 
T4 DNA ligase    New England Biolabs 
T4 DNA polymerase   New England Biolabs 
TaKaRa La TaqHS   TAKARA BIO INC 
Trypsin     GE Healthcare 
 
Table 5: Cell medium 
Medium    Ingredients      
Cell freezing medium  90% [v/v] FCS, 10% [v/v] DMSO 
MitoEagI HEK 293 medium DMEM (4.5 g/L glucose, GlutaMAXTM, 1 mM 
sodium pyruvate), 10% [v/v] FCS, uridine 
(50 µg/L), penicillin & streptomycin (10 U/mL), 
blasticidin S hydrochloride (15 µg/mL), 
hygromycin B (50 µg/mL) 
 
Table 6: Solutions 
Solution Components      
Loading dye 1×TBE buffer, 30% [v/v] glycerol, 0.04% [w/v] 
bromphenol blue, 0.4% [w/v] xylene cyanol 
Cell Lysis buffer 1 mM CaCl2, 3 mM MgCl2, 1 mM EDTA, 
1% Triton X-100, 10 mM Tris, pH 7.5 
Denaturing solution 0.5 M NaOH, 1.5 M NaCl, pH 13 
Depurination solution 0.25 M HCl 
Laemmli buffer 4% SDS, 10% 2-mercaptoethanol, 20% glycerol, 
0.004% bromophenol blue, 0.125 M Tric HCl, 
pH 6.8 
Neutralizing solution 0.5 M Tris-HCl, 1.5 M NaCl, pH 7 
Protein Lysis buffer 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 
1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 
protease inhibitor cocktail (1 tablet/10mL, 
Roche). 
Stripping solution 0.2 M NaOH + 0.1% SDS 
Materials & Methods 
39 
 
Table 7: Kits 
Kit      Supplier      
DIG DNA labelling and detection Kit Roche 
iQ™ SYBR® Green Supermix  BIO-RAD  
QIAamp DNA Mini Kit   QIAGEN N.V.  
QIAquick Gel Extraction Kit  QIAGEN N.V.  
QIAquick PCR Purification Kit  QIAGEN N.V. 
Quant-iT PicoGreen dsDNA Kit  Thermo Fisher Scientific 
PCR DIG Probe Synthesis Kit  Roche 
SYBR Green RT-PCR Reagents Kit BIO-RAD 
 
Table 8: Equipment 
Equipment    Model   Company   
Analytical balance   TE214S    Sartorius 
Camera    3CCD Color     Sony Corporation  
       Model DXC-9100P      
DNA quantitation   Fluorat Panorama  Lumex Instruments 
Gel-electrophoresis chamber  Sub-Cell GT System  BIO-RAD      
Haemocytometer    BLAUBRAND®   BRAND GMBH 
       Neubauer  
Phase contrast    Axiovert 40C  Carl Zeiss AG  
PCR thermocycler    GeneAmp® Applied  Biosystems  
       PCR system 9700 
PCR thermocycler    MJ Research     GMI, Inc. 
      PTC-100      
PCR thermocycler    MJ Research     GMI, Inc. 
Quantitative real time PCR iCycler iQ™   BIO-RAD 
(qPCR) thermocycler   cycler      
Semidry transfer cell  Trans-blot SD  BIO-RAD 
Spectrophotometer   Cary 50 scan   Varian, Inc.   
PTC-200 
Ultrasonic processor  GEX-600   Cole-Parmer 
UV-illuminator    GeldocTMXR   BIO-RAD 
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Table 9: Software 
Software    Program   Company  
DNA quantitation   Fluorometry Panorama Lumex Instruments 
Image processing and analysis ImageJ   Wayne Rasband  
Image acquisition   Quantity One 1-D  BIO-RAD 
     CFX Manager  BIO-RAD  
Analysis Software      
Primer design   Primer-BLAST  NCBI, NLM 
qPCR     MyiQ™   BIO-RAD    
qPCR     IQ5    BIO-RAD 
qPCR     Sigma plot   Systat Software Inc. 
Spectrophotometry  CaryWinUV   Varian, Inc.   
Sequence analysis   scftk      Dr. Zsurka inhouse   
 
Oligonucleotides 
Table 10: Oligonucleotides used in the generation of CRISPR/Cas9-vectors, showing 
gene specific target sites. Note that vectors for MGME1 were purchased directly. 
Gene Target site + PAM (5’–3’) Species Oligonucleotide (5’–3’) 
MGME1 AGACCATTTGCAGGCAGCTCAGG human - 
POLG CCTTTGACCGAGCTCATATCAGG human GGAAAGGACGAAACACCGCTTTGACCGAG
CTCATATCGTTTTAGAGCTAGAAATAGCAA
GTTAAAATAAGG 
EXOG AGTATCGCTTCCCGCCTCCGGGG human GGAAAGGACGAAACACCGGTATCGCTTCC
CGCCTCCGGTTTTAGAGCTAGAAATAGCA
AGTTAAAATAAGG 
APEX2 GCCCTTTAAGATGTTGCGCGTGG human GGAAAGGACGAAACACCGCCCTTTAAGAT
GTTGCGCGGTTTTAGAGCTAGAAATAGCA
AGTTAAAATAAGG 
CAS9UNIV 
- - Phos-AACGGACTAGCCTTATTTTAACTTGC 
TATTTCTAGCTCTAAAAC 
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Table 11: Oligonucleotides used in generating CRISPR/Cas9-mediated knockins. 
Underlined: Changes from wildtype sequences. 
Name Oligonucleotide (5’–3’) 
POLG 
HDRF 
GTCCCTACTGGTGCCAGCAGCCCCACCCAGAGAGACTGGCAGGAGCAGTTAGTGG
TGGGGCACAATGTTTCCTTTGCCCGAGCTCATATCAGAGAGCAGTACCTGATCCAG
GTAAGGTTCCTGGGGCCAACTGCCGGTTCTGGCATGG 
 
Table 12: Primers used for screening CRISPR/Cas9 clones. 
Name Sequence (5’–3’) Annealing temperature (°C)* 
CAS9PLF GAGGGCCTATTTCCCATGAT - 
CAS9PLR TTATGTAACGCGGAACTCCA - 
MGME1F GTTCACTTTTTTCTTCCGGCCAC 62.6 
MGME1R CATCAAAGCGAAAGCTGCATCAG 62.6 
POLGF AAATGCCACAGAGACGAAGG 62.6 
POLGR CCACTCCACAACAACCACTG 62.6 
EXOGF ATCATATTCCCCATCCATCG 62.0 
EXOGR TCTGACCTTTATTCTCCCGG 62.0 
APEX2F CTGAACAGGAAGCAGTTCGC 65.0 
APEX2R CAAGGGGTGGCAAATCAGGA 65.0 
KIR835F GCGCAAAAGCCTCCTCATT 62.5 
KIR903R CCTTCCTTGGTTTGGTGGG 62.5 
MITOEAGIF AACATCACCTCTAGCATCACCAG 54.0 
MITOEAGIR ACCCTCGTGGAGCCATTCATA 54.0 
MT12602F TCATCCCTGTAGCATTGTTCG 55.5 
MT12690R GAAGAACTGATTAATGTTTGGGTCT 55.5 
MT14558F CCCCCATAAATAGGAGAAGGCTTA 55.5 
MT14695R GGTTGTAGTCCGTGCGAGAA 55.5 
18SRRNAF GTTGGTGGAGCGATTTGTCT 55.0 
18SRRNAR GGCCTCACTAAACCATCCAA 55.0 
 
* Temperature is indicated if the oligonucleotide was used for PCR 
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2.1 Cellular model 
MitoEagI cell line was created by Minczuk and colleagues in human HEK 293 
T-REx cells. It holds resistances against blasticidin S and hygromycin B and 
encodes for bacterial restriction endonuclease EagI. EagI was optimized for 
mammalian codon usage, fused with a mitochondrial targeting sequence of 
human COX8B at the N-terminus and a hemagglutinin tag at the C-terminus. 
The construct is expressed under control of a tet-on system, however, even in 
the uninduced state, cells express a small baseline level of mitoEagI (termed 
leaky expression). MitoEagI cleaves the mitochondrial genome within the minor 
arc at a single position (2566/2570), creating 4-nucleotide 5’ overhangs. 
 
2.2 Cell culture 
MitoEagI cells were stored in liquid nitrogen (−195°C) in cryopreservation 
tubes. After quick thawing at 37°C, cells were put into tissue culture flasks 
(75 cm2) with high-glucose Dulbecco’s Modified Eagle Medium (GlutamaxTM 
DMEM, Gibco) containing 10% foetal calf serum (FCS, PAN Biotech), 50 µg/mL 
Uridine, 10 U/mL Penicillin, 10 mg/L Streptomycin (Gibco), 15 µg/mL 
Blasticidin S hydrochloride (Sigma) and 50 µg/mL Hygromycin B (Sigma). 
Approximately 4 hours later, once cells attached, medium was exchanged to 
remove DMSO traces from the freezing medium. Culturing conditions were 
maintained in a humid CO2 incubator at 37°C with 10% CO2 levels. 
 
2.3 Subculturing cells 
Once cells exceeded 95% confluency, they were split. Old medium was aspirated, 
and cells washed once with 1xPBS. To detach cells from the culture flask, a 
2,5 mg/mL solution of Trypsin was added (2 mL for 75 cm2 flasks; 4 mL for 175 
cm2) and cells were incubated for up to 5 min at 37°C. To confirm successful 
trypsinization, cells were checked under a light microscope. Fresh culture 
medium was added to stop the activity of Trypsin (at least 2x volume of Trypsin). 
Resuspended cells were collected in a total volume of 10 mL or 12 mL, 
respectively. Out of this, 50 µL of cell suspension was taken and diluted with 
50 µL of Erythrosine B staining solution [0.1% in PBS] for live/dead cell assays.  
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10 µL of the mix was applied to one counting grid of a Neubauer haemocytometer 
and examined under a light microscope. 4 squares per counting grid were 
examined and concentration of cells/mL was calculated using the following 
formula: 
 
Number of cells/mL = number of counted cells x dilution factor / number of squares x 104 
 
To calculate the total amount of cells in the suspension, the concentration of 
cells/mL must be multiplied by the total volume of which the sample was 
originally taken from. Cells were then either transferred to a larger culture flask 
(175 cm2) or split in volume to attain desired cell numbers and filled up with 
fresh culture medium. Afterwards passaging number of the cell line increased 
by 1. 
 
2.4 Cell pellets 
Trypsinized cells were collected in Falcon tubes (10 mL or 50 mL, filled up with 
1xPBS). If DNA or proteins were to be isolated from cells, pelleting was 
performed at 3000 rpm for 5 min. Supernatant was aspirated, pellet 
resuspended in 1 mL 1xPBS and transferred to an 1,5 mL Eppendorf tube. 
Tubes were centrifuged for 10 min at 6000 rpm. Supernatant was again 
aspirated and cell pellets were frozen at −20°C or directly used for DNA isolation 
or protein purification. Cells for subculture were centrifuged only once, at 
1000 rpm for 10 min, with supernatant aspirated and pellet resuspended in 
fresh culture medium afterwards. 
 
2.5 Cryopreservation of cells 
After cells were pelleted for subculturing, supernatant was aspirated and pellets 
resuspended in ice cold freezing medium (10% DMSO in FCS) to reach 
concentration of 1 x 106 cells/mL. Afterwards, 750 µL were put into each 
cryopreservation tube. Tubes were stored at −20°C for 12−24 hours and 
transferred on ice to −80°C. On the next day, cells were put into liquid nitrogen 
(−196°C) for long-term storage. 
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2.6 Mitochondrial genome linearization by mitoEagI 
MitoEagI HEK cells were grown either on 6-well plates or in 75 cm² flasks until 
90% confluency was reached. Linearization of mtDNA was initiated by the 
addition of 20 ng/mL doxycycline, a member of the tetracycline class, which 
induced the expression of mitoEagI. Cell samples were taken for DNA isolation 
every 2 hours over 18 hours, with additional 24th hour sample.  
For prolonged induction experiments, doxycycline was removed after 24 hours 
and replaced with normal culture medium. Subsequent samples for total DNA 
isolation were taken after 3, 6 and 10 days. 
 
2.7 Mitochondrial DNA depletion 
As described above, mitoEagI HEK cells were grown either on 6-well plates of 
75 cm² flasks until 90% confluency was reached. To start mtDNA depletion, 
2’,3’−dideoxycytidine (ddC) was added to the medium to a final concentration of 
400 µM. Total DNA samples were taken each day over 7 days. Medium was 
changed every second day, also providing fresh ddC (400 µM). On day 2, all 
remaining samples were split to avoid reaching 100% confluency. 
 
2.8 Isolation of total DNA 
Column purification of DNA was performed according to the manufacturers 
protocol (QIAmp® DNA Mini Kit, QIAGEN). Each sample was eluted twice in 
50−150 µL elution buffer provided with the kit and stored at 4°C. 
 
2.9 SgRNA design with synthetic oligonucleotides 
Single guide RNAs (SgRNAs) were selected either from studies in a yeast 
experimental model (POLG) or based on online recommendation tools (EXOG & 
APEX2) like “CHOPCHOP” (Labun et al., 2016) or “Optimized CRISPR Design” 
[Zhang Lab, Massachusetts Institute of Technology, 2016-2017]. All 
oligonucleotides used in the generation of CRISPR/Cas9 plasmids were 
purchased by Integrated DNA Technologies (IDT). For detailed information see 
Table 10 and Table 11. 
 
 
Materials & Methods 
45 
 
2.10 CRISPR/Cas9 sgRNA plasmid construction 
MGME1 knockouts were created using two purchased plasmids from Origene. 
The first plasmid carried a single gRNA against the MGME1 gene in a CRISPR 
vector and the second plasmid coded for Cas9. All other sgRNA plasmids were 
created using the method described by Schmidt et al. (Schmidt et al., 2015).  
In short, a BGH-pA-CMV-gRNA-Cas9 vector was linearized by restriction 
endonuclease digestion (ApaI, SpeI, EcoRV), followed by agarose gel separation 
with purification of the cleaved product, using QIAquick® Gel Extraction Kit. 
Next, T4 polymerase chew-back treatment in the presence of dTTP produced 
long single-stranded overhangs. A short universal reverse-strand 
oligonucleotide was added to create the template vector mix (CAS9UNIV, 
AACGGACTAGCCTTATTTTAACTTGCTATTTCTAGCTCTAAAAC, PAGE 
purified, 5’-phosphorylated, 100 µm, IDT). Gene-specific sgRNA oligonucleotides 
(desalted, 100 µM, IDT) were annealed using the following conditions: 
temperature was gradually decreased from 75°C to 60°C over 37.5 min; 60°C for 
30 min; 60°C to 25°C over 87.5 min. The annealed vector was transformed into 
E. coli without ligation. The bacterial host generates a completely repaired, 
circular plasmid which was isolated with the Plasmid Miniprep Kit (Peqlab) and 
sequenced using CAS9PLF and CAS9PLR primers to confirm the correct 
sequence of the desired hybrid sgRNA. 
 
Figure 14: Ligation-independent cloning (LIC) method. Schematic view of LIC-based 
sgRNA cloning. A plasmid vector is linearized by restriction enzymes ApaI and SpeI. T4 
polymerase chewback reaction in the presence of dTTP creates free 5’ overhangs. Annealing of 
short universal reverse-strand and target-specific oligonucleotides leave a 19 bp sequence 
single-stranded. After transformation in E. coli, bacteria repair and amplification the circular 
plasmid, containing the desired hybrid sgRNA sequence (method and figure adapted from 
Schmidt et al., 2015). 
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2.11 CRISPR/Cas9 transfection 
MitoEagI HEK 293 T-REx cells were plated at a density of 1 x 104 cells per 96-
well, in 100 µL culture medium. On the next day, cells were transfected with 
200 ng of CRISPR/Cas9 plasmids using GeneJuice transfection reagent 
(Novagen) according to the manufacturers protocol. For creating the POLG 
knockin, an additional 148 bp single-stranded oligonucleotide (POLG_HDRF) 
was co-transfected.  
This oligo represented the target region of the POLG gene, but carried the 
desired missense point mutation as well as silent point mutations for disrupting 
the protospacer adjacent motif (PAM) and a restriction endonuclease site (PstI). 
 
2.12 Single cell cloning 
Transfected cells were monitored each day by optical and fluorescence light 
microscopy for up to 48 hours post transfection. Transfection efficiency was 
assessed by DsRed quantification, expressed by CRISPR/Cas9 plasmids. 
Usually, efficiency increased with passing days, however, correlated Cas9 
activity is prognosed to last only for up to 48 hours. For single cell cloning, 
transfection medium was carefully removed and replaced by 100 µL fresh 
culture medium, which was used to wash the well in order to detach the cells. 
Cell suspension was collected in an 1.5 mL Eppendorf tube. Half of its volume 
(50 µL) was used for cell counting and diluted only with 50 µL Erythrosine B 
staining solution. 5 cells/mL were set as a final concentration for single cell 
cloning, using 100 µL final volume per 96-well. If the required volume of cells 
was below 1 µL, a predilution was performed. 50 µL of cell suspension were 
diluted in 5 mL culture medium (new dilution factor 100). The required volume 
of cells is then also multiplied by the new dilution factor (x100). 96-well plates 
were incubated at 37°C with 10% CO2 for 2 weeks. 
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2.13 CRISPR/Cas9 clone screening 
After 2 weeks incubation from single cell cloning, wells can be analysed under a 
light microscope and screened for the formation of colonies. Only singular 
colonies per well were pursued for screening. Medium was carefully removed 
and replaced by 200 µL fresh culture medium, which was used to wash and 
detach cells from the well. 100 µL were transferred to a new 96-well plate and 
filled up to 200 µL for further growth. The other 100 µL were transferred to a 
PCR microtube and spun down at 2000 g for 1 min. The cellular pellet was 
resuspended in 20 µL lysis buffer (1 mM CaCl2, 3 mM MgCl2, 1 mM EDTA, 
1% Triton X-100, 10 mM Tris pH 7.5) containing proteinase K (0.2 mg/mL, 
Qiagen). The reaction was incubated at 65°C for 10 min, followed by heat 
inactivation at 95°C for 15 min. Lysates were directly used for PCR 
amplification and subsequent Sanger sequencing. As for knockin clones, PCR 
amplification products were screened for the loss of the PstI restriction sites, 
prior screening (digested at 37°C for 1h). 
 
2.14 PCR detection 
PCRs performed used the AccuTaq polymerase with 20 ng of total DNA in a 
12.5 µL reaction mix (see conditions below). Primer specific annealing 
temperatures were optimized before, for each primer pair. 
PCR conditions (annealing temperature changed between primer pairs). 
95°C 2.5 min 
95°C 15s 
50−68°C 2 min 
72°C 10 min 
 
Reagent Volume (µL) 
10x AccuTaq buffer 1.25 
dNTPs (2.5 mM) 1.25 
PrimerF (50 pmol / µL) 0.1 
PrimerR(50 pmol / µL) 0.1 
Jumpstart AccuTaq 0.125 
DNA (20 ng / µL) 1 
42 cycles 
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2.15 Agarose gel electrophoresis 
5 µL of PCR product was mixed with 5 µL loading buffer (5x) and loaded on an 
agarose gel (1–2%). Percentage changed, depending on the expected PCR 
product size. A 1 kb DNA or 2-log DNA ladder was used as reference for band 
identification. Voltage and duration were kept constant at 180 V for 60 min. 
Images were captured with the camera of the UV-illuminator GelDocTM XR at 
excitatory wavelengths between 254 and 365 nm. 
 
2.16 Polyacrylamide gel electrophoresis (PAGE) 
PCR products smaller than 300 bp were separated on 10% polyacrylamide gels 
at 30 mA for 40 min. 
Reagent Volume (mL) 
H2O 5.4 
TBE 2 
Acrylamide/Bis, 40% 2.5 
APS, 10% 0.1 
TEMED 0.01 
 
Afterwards, gels were stained in 35 mL TBE buffer + 5 µL SYBR Green for 
15 min, while shaking. Visualization was exactly as for agarose gel 
electrophoresis. 
 
2.17 Sanger sequencing 
PCR amplification products were purified, using the ExoSAP PCR product 
cleanup reagent (Thermo Scientific) according to the manufacturer’s protocol 
and subsequently diluted in H2O. Sanger sequencing of the purified PCR 
products was performed by a commercial sequencing service (Eurofins). 
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2.18 Quantitative PCR (Real-time) 
Total DNA was diluted 2-fold, starting from 20 ng and was used in triplets per 
concentration for quantitative real-time PCR. DNA was mixed with a SYBR 
Green Supermix, from the SYBR Green RT-PCR Kit (BIO-RAD), containing also 
a primer mix (12.5 pmol) for either the mitochondrial EagI gene 
(MITOEAGIF+R) or the nuclear Kir gene (KIR835F+Kir903R).  
 
PCR reactions were performed on an iQ5 qPCR system (BIO-RAD) under the 
following conditions:  
95    °C for 5 min 
95    °C for 15 sec 
62,5 °C for 30 sec 
 
CT values were analysed by SigmaPlot and defined at the inflection points of 
fitted sigmoidal regression curves (4-paraters Chapman curves, Zhao and 
Fernald, 2005). The sigmoidal regression curve had four parameters −y0, a, b 
and c, which determined the shape and degree of the exponential function. The 
parameters were gained from the software using this formula: 
 
y = y0 + a (1 – e-bx)c 
 
The CT value, calculated at the inflection point of the sigmoidal curve were 
calculated with the following formula: 
 
CT = ln(c) / b 
 
Mean and standard deviation was calculated for each sample triplet and per 
serial dilution. Next, cycle number differences were calculated by subtracting 
the CT values of the mtDNA fragment (CTmito) from the CT values of the nuclear 
reference gene (CTnuc). To determine mitochondrial copynumbers (CNmt), the 
ratio between the diploid single nuclear gene and the mitochondrial sequence 
was calculated. 
 
45 cycles 
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2.19 Protein purification 
Pelleted cells were resuspended in Lysis buffer (~100 µL/mio cell) on ice, before 
sonicated 2 times for 15 s with ultrasonic processor GEX-600 (8% Amplitude), 
followed by 30 min shaking at 4°C. After centrifugation (20 min, 10.000 g) 
supernatant (lysate) was taken for analysis and protein concentration 
measurement (Peterson’s modification of the micro-Lowry method). 
 
For SDS-PAGE lysate (15 µg protein per lane) was diluted in 4xLaemmli buffer. 
After addition of small amount of β-mercaptoethanol (1 µL in 20 µL total volume) 
lysate/Laemmli solution was heated at 95°C for 5 min. 
 
2.20 Glycine SDS-PAGE 
Glycine sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) 
was performed to separate proteins according to their molecular weight. 1x SDS-
running-buffer (25 mM Tris, 1.92 M Glycine, 0.1% [w/v] SDS) was used for 
conducting electrophoresis at 100 V for 30 min, and 130 V for 1–1.5 h. 
 
Reagent Volume (mL) 
Resolving gel (10%) 
Volume (mL) 
Stacking gel 
Acrylamide/bis (30/0.8) 5.7 0.83 
1.875 M Tris pH 8.8 3.5 - 
0.8 M Tris pH 6.8 - 0.5 
10 % [w/v] SDS 0.17 0.05 
ddH2O 7.5 3.55 
10 % [w/v] APS 0.1 0.05 
TEMED 0.01 0.01 
 
2.21 Western blot 
Proteins separated by SDS-Page were transferred to a polyvinylidene fluoride 
(PVDF) membrane using semi-dry Western blot technique. PVDF membranes 
were activated in 70% ethanol for 5 min and washed in blotting buffer (20 mM 
Tris, 150 mM glycine, 0.02% SDS). Filter papers were soaked in blotting buffer 
and put above and below gel with PVDF membrane. Blotting was performed at 
max. 100 mA for 1.5 h (while not exceeding 25 V). Membranes were stained with 
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Coomassie Brilliant Blue R-250 Staining Solution (BIO-RAD) followed by 
destaining solution (30% methanol, 10% acetic acid) for visualization of total 
proteins. For complete destaining, the membranes were treated with methanol. 
After washing in water 3 times in PBST solution (PBS, 0.1% Tween 20), the 
blocking (5% dry milk in PBS) was performed for 1h. After washing twice in PBS 
and then in PBST, primary antibodies were diluted in PBST containing 2% dry 
milk and used for O/N incubation at 4 °C. On the next day, membranes were 
washed three times in PBST, containing 1% Triton X-100, followed by 
incubation with anti-rabbit antibody coupled to horseradish peroxidase 
(1:20.000, diluted in PBST containing 2% dry milk) 1 h at room temperature.  
After washing three times in PBST and once in PBS, the membranes were 
treated with SuperSignal West Pico Chemiluminescent Substrate (Thermo 
Scientifc) according to the manufacturer manual. Detection of western blot 
signals was recorded on a ChemiDoc Imaging System (Bio-Rad) at different 
exposure times (10–60 s). 
 
2.22 Nucleic acid quantitation 
Concentration of isolated total DNA was calculated by measuring optical density 
(OD) with spectrophotometer. Absorption of ultraviolet light shows maximum 
for double-stranded DNA at wavelength λ = 260 nm, for proteins at λ = 280 nm. 
DNA concentration (C) in ng/µL is calculated by the following formula:  
 
C = [-36.0(OD 280nm – OD 320nm) + 62.9(OD 260nm – OD 320nm)] × dilution factor 
 
Multiplying DNA concentration C by the purified sample volume (mL) gives the 
total yield of isolated DNA (µg). Purity of DNA is provided by the OD ratio of 
260nm/280nm.  
DNA ratios between 1.8 and 2 were considered of suitable quality. DNA 
impurities can be detected at λ = 320 nm, OD 320nm, using the following 
formula: 
 
DNA purity = (OD 260 nm – OD 320 nm) / (OD 280 nm – OD 320 nm). 
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2.23 DNA quantitation using PicoGreen® 
1 µL DNA sample was diluted in 180 µL of TBE. Lambda calibration curve was 
established through a 5x serial dilution in 180 µL TBE. DNA and Lambda 
samples were mixed with 180 µL of PicoGreen + 1x TBE (1:200). Emission range 
was set between 500−600 nm, with expected peak of emission at 520 nm. Each 
sample was read in a Lambda-2 Spectrophotometer with a quartz cuvette 
against a TE blank plus calibration curve. 
 
2.24 Southern blot 
1 µg of total DNA was digested for 2 hours at 37°C with 1 µL BamHI (restriction 
endonuclease, 20.000 U/mL, New England Biolabs), loaded on an 0.6% agarose 
gel and separated over night at 40 V, using the 1 kb extended DNA ladder (New 
England Biolabs) and DIG-labeled DNA Molecular Weight Marker II or III 
(Roche). On the next day, gels were treated with 250 mM HCl for 30 min, rinsed 
with ddH2O and washed twice with denaturation buffer for 20 min each, rinsed 
again with ddH2O and washed twice with neutralization buffer for 20 min each, 
before blotted to Zeta-Probe membranes (Bio-Rad) in 2xSSC buffer overnight. 
On the next day, membranes were washed in 1xSSC buffer to remove agarose 
traces. Afterwards, DNA was immobilized on membranes by baking at 80°C for 
30 min. Blots were put into hybridization tubes (DNA facing inward and 
upwards) and tubes put into rotating oven. Pre-hybridization of membranes was 
performed for 3 hours in DIG Easy Hyb buffer (Sigma) at 48°C. Two different 
PCR-generated digoxigenin-labelled mtDNA probes (PCR DIG Probe Synthesis 
Kit, Roche) were used, located on either of the BamHI cutting site (1st probe at 
region 12602–12690; 2nd probe at region 14588–14695). A nuclear ribosomal 
DNA (18S) probe served as quantification reference. 20 ng/mL DIG-probe was 
hybridized per blot in hybridization buffer overnight, at 48°C. On the next day, 
washing and blocking steps were performed according to the manufacturers 
protocol (Roche), using anti-DIG-AP antibody Fab fragments (Roche). For 
chemiluminescent detection, blots were treated with CSPD (Roche) and 
incubated 10 min at room temperature followed by 15 min at 37°C. Signal was 
recorded on a ChemiDoc Imaging System (Bio-Rad) at different exposure times 
(50–300 s).  
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To remove DIG-probes, blots were treated twice with stripping buffer at 37°C 
(0.2 M NaOH + 0.1% SDS), for 15 min each, followed by a quick rinse in 2xSSC, 
before continuing pre-hybridization for 3 hrs and probe hybridization over night 
at 48°C. 
 
2.25 Southern blot quantification 
Semiquantitative analysis on southern blot fragments was performed using the 
image processing program ImageJ. The region of interest (ROI) was marked per 
fragment and analysed by the program for area (A) and mean signal intensity 
(MSI), on a 255-bit image. A background triplet was also marked per lane, to 
calculate a background mean (BG), which was subtracted from its corresponding 
lanes ROI.  
To determine the signal intensity, the following formula was used: 
 
signal = (MSIROI – MSIBG) * AROI 
 
To quantify degrees of mtDNA degradation, a ratio was formed between the 
mitochondrial signal (signalmito) and its 18s ribosomal DNA signal (signal18s), to 
calculate a normalized signal (signalnorm) for each lane. For relative 
quantification, 0 h values were used as reference value (1) against each 
individual signalnorm. 
 
 
 
 
 
 
 
Results 
54 
 
3. Results 
3.1. Effects of mitochondrial nuclease activity on linear mtDNA 
Exonuclease activity of mitochondrial nucleases is most often described in the 
context of flap intermediate processing and proofreading during mtDNA 
replication as well as in mtDNA repair (Copeland et al., 2008) while mtDNA 
degradation is still hypothesized to be performed by an uncharacterized 
pathway and not by known mitochondrial nucleases (Moretton et al., 2017). To 
address these questions, if and how mitochondrial nucleases are involved in the 
degradation of linear mtDNA, the CRISPR/Cas9-system was used to alter the 
genes of known mitochondrially-targeted exonucleases in the mitoEagI HEK 
293 cell line. 
 
3.1.1 Monitoring degradation of linearized mtDNA in human cells 
The modified HEK 293 T-REx cell line, expressing the mitochondria-targeted 
restriction endonuclease EagI under the control of a tet-on system was used in 
this study (created by Dr. M. Minczuk and colleges). Upon induction with 
doxycycline, mitoEagI cleaved the mitochondrial genome at a single position 
within the minor arc (position 2566/2570), creating a double-strand break with 
5’-overhangs. These overhangs serve as starting points for mitochondrial 
exonucleases, which will degrade the now linearized mtDNA over time, 
resulting in a steady decrease of mitochondrial copy numbers. This makes the 
mitoEagI HEK cell line a useful tool for studying kinetics of linear mtDNA 
degradation. It is noteworthy, that even in the absence of doxycycline, there is 
a small baseline expression of the mitoEagI protein (termed leaky expression) 
which cuts mtDNA. 
 
Linearized mtDNA was monitored over the first twenty-four hours, with 
samples taken each second hour. Total DNA was used for RT-PCR with primers 
spanning the mitoEagI cutting site, inside the mitochondrial genome (Figure 
15). Data showed, about 80 % of mtDNA was linearized four hours after 
mitoEagI induction. The remaining proportion of circular mtDNA continued to 
decrease over the time-course and reached below 5 % after twenty-four hours.  
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This confirmed the nuclease activity of mitoEagI, which lead to the successful 
cleavage and linearization of circular mtDNA followed by its subsequent 
degradation.  
 
   
 
 
 
Figure 15: Inducible mitoEagI model for linearizing mtDNA. Time curve showing 
mitoEagI restriction efficiency over time in induced mitoEagI HEK cells, through RT-PCR 
kinetics, spanning the cutting site (E), over the first 24 h. Copy numbers were normalized to 
zero-hour data.  
 
3.2 Generation of CRISPR/Cas9-edited knockout and knockin cell 
lines, with targeted mitochondrial exonucleases 
Having the mitoEagI model established to linearize mtDNA, now the 
mitochondrial nucleases had to be investigated separately in their effect on 
linear mtDNA degradation. Genome editing was performed on the following 
members with known mitochondrial nuclease function: MGME1, POLG, EXOG 
and APEX2. Using the CRISPR/Cas9 system on mitoEagI expressing HEK 293 
T-REx cells, knockouts (ko) were created for MGME1, EXOG and APEX2, 
respectively (Figure 16). Only clones with homozygous frameshift indels 
(insertions or deletions) were used for subsequent experiments. A complete 
knockout of polymerase γ  would result in the loss of mtDNA over time, since 
mtDNA replication can no longer be performed and was therefore not applicable 
with the intention to analyse linear mtDNA degradation in this work.  
Hence, the p.D274A point mutation was introduced in the POLG gene, which 
had been reported to selectively silence the 3’–5’ exonuclease activity of POLG 
in yeast and mouse (Vanderstraeten et al., 1998; Trifunovic et al., 2004). Two 
additional silent mutations were introduced as well, one to alter the gRNAs 
PAM site, preventing Cas9 from further endonuclease activity and one to 
remove a PstI restriction site, allowing for easier screening later on.  
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Figure 16: Schematic process of the generation of CRISPR/Cas9-edited HEK cell lines. 
Transfection with CRISPR/Cas9-plasmids, bearing an additional gene-specific target sequence 
(gRNA) was performed on HEK cells. After single cell cloning on 96-well plates with subsequent 
incubation time, DNA samples were taken from grown colonies for PCR amplification of the 
targeted gene. Following agarose gel screening, prominent indels were sent for Sanger 
sequencing for genotyping. 
 
 
Detailed cloning information per targeted gene can be taken from Table 13 
below. 
 
 
 
 
 
 
Sanger sequencing 
Mutation screening of MGME1 target site 
(*deletion: c.24_37del14)  
 
* 
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Table 13: Cloning statistics per CRISPR/Cas9-targeted gene in HEK cells. Total number 
of individual mitoEagI HEK colonies listed against the number of screened clones with a 
successful knockout / knockin and the corresponding CRISPR/Cas9-editing efficiency. 
 
 
Gene target 
Total 
number of 
colonies 
Number of 
successful 
knockouts / 
knockins 
 
Efficiency 
% 
MGME1 288 2 0,7 
POLG 460 1 0,2 
EXOG 18 2 11 
MGME1 + EXOG 19 2 10,5 
APEX2 34 2 6 
 
One of the greater challenges in creating CRISPR/Cas9-edited HEK cell lines 
with altered mitochondrial nucleases was establishing a streamlined work-
pipeline, which allowed for a high throughput of culture plates (and clones) with 
a reliable, but fast screening technique. Differences between the commercially 
acquired vector against MGME1 and the custom generated BGH-pA-CMV-
gRNA-Cas9 vector (used for all other targeted genes) were not investigated. For 
the double-knockout of MGME1+EXOG, the MGME1 knockout cell line was 
used, in which EXOG was targeted second. The POLG p.D274A point mutation 
showed a very low efficiency, which was expected, because homologous 
recombination with the co-transfected oligonucleotide template was much less 
likely to occur than NHEJ (Mao et al., 2008). Except for POLG, all other clones 
were directly screened for indels by Sanger sequencing. POLG clones were 
digested by PstI prior sequencing and only undigested PCR bands, bearing the 
mutated knockin represented clones of interest. 
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The screening results (Figure 17) presented two knockout clones for MGME1, 
both having frameshift deletions (14 bp and 8 bp, respectively), one POLG 
knockin with the desired p.D274A point mutation, one knockout clone for EXOG 
(T duplication) and one knockout clone for APEX2 (C duplication). Two double-
knockout clones for MGME1 + EXOG were created as well (data not shown).  
The POLG knockin clone first appeared to be a polyclonal mixture. Therefore, a 
second round of single cell cloning was performed from that clone, producing 30 
sub-clones in total, with 6 bearing the homozygous, monoclonal knockin. 
Figure 17: CRISPR/Cas9-edited genes in mitoEagI HEK cells. Sanger sequencing data 
showing knockouts for MGME1, EXOG and APEX2 as well as p.D274A knockin of POLG in 
mitoEagI expressing HEK cells. Corresponding amino acids are shown on top of each sequence 
(black colour: wild type sequence; red colour: mutated sequence), indels or point mutations are 
shown below the sequences (figure adapted from Peeva and Blei et al., 2018). 
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The mutator cell lines had to be examined for their expression of the mitoEagI 
protein, which was crucial in order to study linear mtDNA degradation. Through 
Western blotting, the hemagglutinin epitope of the restriction endonuclease was 
targeted in an uninduced (zero hour) and induced (twenty-four hour) state 
(Figure 18). 
 
Figure 18: Western blot analysis of mitoEagI protein expression in CRISPR/Cas9-
modified mitoEagI HEK cells. Whole cell protein extracts were used for mitoEagI protein 
detection, through targeting the hemagglutinin epitope (HA). Blot shows samples of the induced 
(+) and uninduced (-) state from MGME1, POLG, control, APEX2 and EXOG clones. β-actin was 
used as reference control. 
 
The comparison between uninduced state at zero hour and induced state after 
twenty-four hours showed a strong signal for mitoEagI in all induced cell lines. 
The control itself was a non-mutated wild-type single-cell clone, originating from 
CRISPR/Cas9 editing to check whether off-target effects from Cas9 would 
influence the doxycycline induction.  
 
This showed, that mitoEagI was stably expressed upon induction and that this 
induced expression did not decay over the chosen time frame of twenty-four 
hours, used for the experiments performed in this work. Notably, the previously 
mentioned leaky expression of mitoEagI in the uninduced state was not strong 
enough to create a signal, which could be detected by Western blotting.  
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After mitoEagI protein expression was confirmed in HEK clones, endonuclease 
activity of mitoEagI on circular mtDNA was analysed six hours after induction 
(Figure 19). Induction efficiency of mitoEagI on mtDNA was checked, as before, 
with RT-PCR spanning the cutting site in all clones.  
 
Figure 19: Induced mitoEagI endonuclease activity on circular mtDNA in 
CRISPR/Cas9-edited HEK cells. The bar graph shows the amount (%) of remaining circular 
mtDNA 6 h after mitoEagI induction, per HEK cell line. The data were normalized to their 
respective 0 h value. 
 
The control showed no significant difference in mitoEagI cutting efficiency six 
hours after induction, compared to previous results (Figure 15). As mentioned 
before, the control originated from CRISPR/Cas9-treated single-cell clones, 
failing to show genome-editing effects for the targeted gene. Knockout clones 
(MGME1, EXOG, MGME1 + EXOG, APEX2) also showed similar cutting 
efficiency as control (10-22 % of remaining circular mtDNA). POLG knockin 
clone still had 46 % of circular mtDNA remaining, six hours after induction, 
which can be explained by the high passage number, resulting from the required 
second single cell dilution. Additionally, at later timepoints (8 h and more) this 
clone showed similar, comparable numbers of cleaved circular mtDNA (data not 
shown). 
Together, this data showed that CRISPR/Cas9-edited mitoEagI HEK cells were 
still able to inducibly express the mitoEagI protein and that its endonuclease 
activity was comparable in its cutting efficiency to controls. Only the POLG 
clone showing lower cutting efficiency than the other clones, but it was still 
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enough to address the question of interest, namely whether or not POLG is 
involved in the degradation of linear mtDNA. Testing for the expression of the 
mitoEagI protein and its cutting efficiency on circular mtDNA also showed, that 
CRISPR/Cas9-editing did not alter the ability of mitoEagI to linearize circular 
mtDNA. 
 
3.3 Effects of mitochondrial exonuclease activity on linear mtDNA 
in induced CRISPR/Cas9-modified human cells 
MitoEagI HEK cell lines with altered genes of mitochondrial nucleases were 
examined together with controls for effects on degradation of linear mtDNA.  
Control showed, through Southern blotting of total DNA (Figure 20 a), full-
length mtDNA at zero hour (uninduced state). Leaky expression was not 
detectable via Southern blotting, probably due to the fast degradation of the 
linearized molecules. After induction, full-length fragment was still present 
after two hours, but with decreased band intensity (Figure 20 b) and Southern 
blot showed the additional formation of a smaller-sized fragment. Rapid 
degradation of the full-length fragment was observed after that time point, 
reaching 75–90 % of mtDNA being cleaved and linearized. At two hours, the 
fragment with ends originating from the original mitoEagI cutting site was 
detectable (Figure 20 c). After four hours, this fragment turned into a mixture 
of smaller-sized mtDNA fragments, with prominent bands ranging from a few 
hundred to up to several thousand base pairs downstream the mitoEagI cutting 
site. Another prominent band in this mix corresponded to a fragment spanning 
from oriL to mitoBamHI cutting site, which started showing signs of decay at 
eighteen hours. In summary, induction of the mitoEagI protein in control 
showed rapid linearization of circular mtDNA as well as strong degradation 
effects of linear mtDNA, performed by mitochondrial exonucleases starting from 
free ends. 
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3.3.1 Rapid degradation of linear mtDNA fragments is absent in 
POLG knockin and MGME1 knockout during the first 24 hours 
Southern blotting of total DNA showed for POLG p.D274A clone a clearly visible 
full-length fragment at zero hour, too. Linearization of full-length mtDNA was 
slightly delayed, when compared to control (Figure 20 b), but reached 
comparable levels at later time points. The mitoEagI fragment showed increased 
intensity over time and almost no signs of degradation (loss of signal), over the 
first eighteen hours (Figure 20 c). Also the smaller-sized mix, formed due to 
degradation from the ends, was not detectable in POLG p.D274A clone. Notably, 
degradation of the bands, produced by mitoEagIs leaky expression resulted in 
the formation of some smaller sized fragments as well, including the mitoEagI 
and oriL bands. 
 
 
Figure 20: Degradation of the linearized mtDNA fragment in control, POLG- and 
MGME1-mutant mitoEagI expressing HEK cells, showing the large digested fragment. 
a) Southern blot showing degradation of the large linear mtDNA fragment, spanning from 
mitoEagI cutting site (E) till BamHI cutting site (B) in control, POLG p.D274A and MGME1 ko 
cells within the first 18 hours of induced mitoEagI expression. BamHI endonuclease was used 
to linearize circular, full-length mtDNA. Position of probe 1 is indicated by a black asterisk (*) 
on the simplified mitochondrial genome (right), close to the BamHI cutting site. Note that the 
most prominent bands in control hour 4–8 are slightly smaller than the non-degraded linearized 
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mitoEagI fragment visible at 2 h. Southern blot quantification of b) full-length fragment shows 
efficient linearization of mtDNA and c) persistency of the mitoEagI fragment in POLG and 
MGME1 mutant cells. Relative intensity was calculated with a probe against a nuclear 
ribosomal DNA (18S). Existing mitoEagI and oriL bands in POLG and MGME1 mutator cells at 
zero hour formed due to leaky expression of mitoEagI. Data represents the mean of three 
independent experiments. Error bars indicate the standard error of the mean (SEM). 
 
MGME1 knockout cells also showed a clear full-length fragment at zero hour 
and a comparable degradation of this fragment over time in comparison to 
control. An additional oriL fragment was detectable at zero and two hours 
(Figure 20 a). The mitoEagI fragment persisted in MGME1 ko clone as well, but 
appeared with sharper bands compared to the POLG knockin. The persistence 
of the mitoEagI fragment in MGME1 ko over the first eight hours was also 
similar to POLG clones (Figure 20 b) and indicated the absence of rapid 
degradation of linear mtDNA in this clone. Only after eighteen hours, the 
mitoEagI fragment started to lose intensity. 
 
Using the small fragment probe ( ) allowed for the evaluation of the smaller 
mtDNA fragment produced by mitoEagI and BamHI cutting (Figure 21 a). 
Linearization of full-length mtDNA showed a comparable pattern as with probe 
1 in all clones (Figure 21 b). The mitoEagI fragment in control showed again 
rapid signs of degradation–after four hours it was very weak, but still detectable 
(Figure 21 c) and its smaller fragments were completely degraded after eight 
hours. The persistence of the mitoEagI fragment in MGME1 ko was slightly 
higher than in POLG p.D274A and also showed sharper bands for MGME1 ko, 
which could indicate partial degradation for POLG might start sooner than in 
MGME1 ko. Leaky expression of mitoEagI at zero hour was visible in MGME1 
ko cells. 
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Figure 21: Degradation of the linearized mtDNA fragment in control, POLG- and 
MGME1-mutant mitoEagI expressing HEK cells, showing the small digested fragment. 
a) Southern blot showing degradation of the small mtDNA fragment, produced by mitoEagI (E) 
and BamHI (B) endonuclease activity in control, POLG p.D274A and MGME1 ko cells within 
the first 18 hours of induced mitoEagI expression. BamHI endonuclease was used to linearize 
circular, full-length mtDNA. Position of probe 2 is indicated by a white X on the simplified 
mitochondrial genome (right), close to the BamHI cutting site. Southern blot quantification of 
b) full-length fragment shows efficient linearization of mtDNA and c) persistency of the 
mitoEagI fragment in POLG and MGME1 mutant cells. Relative intensity was calculated with 
a probe against a nuclear ribosomal DNA (18S). Existing mitoEagI and oriL bands in POLG and 
MGME1 mutator cells at zero hour formed due to leaky expression of mitoEagI. Data represents 
the mean of two independent experiments. Error bars indicate the standard error of the mean 
(SEM).  
 
Overall, both probes detected a successful linearization of circular mtDNA by 
mitoEagI in control and mutated HEK cells. Even though the POLG p.D274A 
clone showed the lowest cutting efficiency of mitoEagI, it was still enough to 
produce strong signals for the mitoEagI fragment, which was required to study 
degradation of linear mtDNA. Both clones showed persistence of the mitoEagI 
fragment during the first eight hours, compared to the control. Interestingly, 
mitoEagI bands on Southern blot appeared sharper for MGME1 ko and slightly 
lower and blurred or POLG knockin, indicating at least partial degradation. 
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Also, the detectable mitoEagI ends of the large mtDNA fragment showed higher 
persistence in the POLG clone, after six hours of induction (Figure 20c), 
compared to the MGME ko clone. When comparing mitoEagI ends in the small 
mtDNA fragment, their persistence was higher in MGME1 ko clone, which 
remained over eighteen hours. POLG knockin clone showed strong persistence 
only until six hours past induction for the smaller fragment with decreasing 
intensity at eight hours and beyond, with only a mixture of smaller sized 
fragment remaining after eighteen hours. Leaky expression (zero−hour 
intensity) of mitoEagI bands was higher in MGME1 clone, which would explain 
differences to POLG at early hours after induction.  
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3.3.2 EXOG and APEX2 knockouts show no degradation 
deficiencies on linear mtDNA 
With POLG and MGME1 showing both significant differences in terms of linear 
mtDNA degradation towards control, the next tested set of mitochondrial 
exonucleases included mutant clones for EXOG and APEX2 knockout cells. 
After mitoEagI induction, the large fragment of linearized mtDNA was 
visualized via Southern blotting (Figure 22 a) and revealed comparable results 
of mitoEagIs cutting efficiency in both mutated cell lines on the circular mtDNA 
(Figure 22 b). 
 
 
 
 
Figure 22: Degradation of the linearized mtDNA fragment in MGME1-, EXOG- and 
APEX2-knockout mitoEagI expressing HEK 293 cell lines, showing the large digested 
fragment. a) Southern blot, showing degradation of the large mtDNA fragment between 
mitoEagI (E) and BamHI (B) cutting site, within the first eighteen hours after mitoEagI 
induction. Total DNA was treated with BamHI endonuclease to linearize circular, full-length 
mtDNA. Position of probe 1 is indicated by a black asterisk (*) on the simplified mitochondrial 
genome (right), close to the BamHI cutting site. The prominent bands after 4 hours in EXOG ko 
and APEX2 ko cells are slightly smaller than the non-degraded linearized mitoEagI fragment, 
visible after 2 hours. Quantification shows degradation of b) full-length and c) mitoEagI 
fragment during the first 18 hours, after induction, with no persistency of the mitoEagI 
fragment. Relative intensity was calculated with a probe against a nuclear ribosomal DNA 
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(18S). Data represents the mean of two independent experiments. Error bars indicate the 
standard error of the mean (SEM). 
Two hours after induction, the DNA fragment belonging to the original mitoEagI 
cutting site was formed in EXOG-/- and APEX2-/- cells, but got rapidly degraded 
into a composition of complex smaller-sized fragments (Figure 22 a, c). Leaky 
expression and lack of degradation seemed to be not as prominent as in the other 
mutant cell lines and resembled more the control, too.  
Visualizing the small mtDNA fragment between mitoEagI and BamHI cutting 
sites (Figure 23 a), using probe 2 revealed similar linearization patterns on full-
length fragments during the first eighteen hours (Figure 23 b).  Detection of the 
mitoEagI fragment showed a strong signal at two hours, with weak, but still 
detectable bands at later time points (Figure 23 c). 
 
 
Figure 23: Degradation of the linearized mtDNA fragment in MGME1-, EXOG- and 
APEX2-knockout mitoEagI expressing HEK 293 cell lines, showing the small digested 
fragment. a) Southern blot, showing degradation of the small mtDNA fragment between 
mitoEagI (E) and BamHI (B) cutting site, within the first eighteen hours after mitoEagI 
induction. Total DNA was treated with BamHI endonuclease to linearize circular, full-length 
mtDNA. Position of prob 2 is indicated by a white X on the simplified mitochondrial genome 
(right), close to the BamHI cutting site. Quantification shows degradation of b) full-length and 
c) mitoEagI fragment during the first 18 hours, after induction, with no persistency of the 
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mitoEagI fragment. Relative intensity was calculated with a probe against a nuclear ribosomal 
DNA (18S). 
 
3.3.3 Long term effects of linear mtDNA degradation in 
mitochondrial nuclease-deficient mitoEagI HEK clones 
Following the investigation of linear mtDNA degradation in mitochondrial 
nuclease-deficient mitoEagI HEK cell lines, degradation effects after prolonged 
mitoEagI induction were studied. For this purpose, doxycycline was removed 
from the medium after twenty-four hours, with clones being monitored over ten 
days total. Total DNA was again treated with BamHI to linearize circular 
mtDNA and visualized by Southern blotting (Figure 24 a-c). 
 
Circular mtDNA was again almost completely linearized by mitoEagI after 
twenty-four hours of induction in all clones (Figure 24 d). Presence of the 
mitoEagI fragment was detectable between zero hour (due to leaky expression 
of mitoEagI) and one day after induction in POLG p.D274A, MGME1 ko and 
MGME1 + EXOG double ko cells (Figure 24 e). POLG knockin showed on day 
three a slightly smaller-sized mitoEagI fragment, with an additional mix of 
smaller fragments below. This mixture was previously detectable in control, 
EXOG ko and APEX2 ko cells, but after a much shorter time point (four hours 
after doxycycline induction). Interestingly, while the full-length fragment 
seemed to recover in POLG knockin starting at day six (Figure 24 a, d), the 
mitoEagI fragment got further degraded and reduced in size. 
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Figure 24: Long term degradation effects on the linearized mtDNA fragment in 
mitoEagI expressing HEK clones, showing the large digested fragment. Cells were 
incubated over the first 24 hours in the presence of doxycycline, then doxycycline was removed 
from the media and incubation continued over 10 days. Southern blots showing degradation of 
the larger mtDNA fragment, spanning from the mitoEagI (E) and BamHI (B) cutting site. Total 
DNA was treated with BamHI endonuclease to linearize circular, full-length mtDNA. Position 
of probe is indicated by a black asterisk (*) on the simplified mitochondrial genome, close to the 
BamHI cutting site. Linear mtDNA degradation of a) control and POLG p.D274A, b) MGME1 
ko plus MGME1-EXOG double ko and c) EXOG ko plus APEX2 ko clones shows rapid 
degradation in control and knockout clones. Note that Figure b shows the same Southern blot, 
with only the middle part removed. POLG knockin clone shows the complex mixture of smaller-
sized fragments of the original mitoEagI fragment 3 days after induction started. Quantification 
of d) full-length and e) mitoEagI fragments in selected clones was calculated, using a nuclear 
18S ribosomal DNA probe as reference. 
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Double knockout of MGME1 and EXOG showed an almost identical degradation 
pattern as the MGME1 knockout alone (Figure 24 b, d, e), indicating no 
additional participation of EXOG to degradation of linear mtDNA during the 
chosen time frame. The smaller-sized oriL fragment also got rapidly degraded, 
already after twenty-four hours in control, EXOG and APEX2 knockout cells. 
Persistence of the oriL fragment was detectable in POLG knockin, MGME1 
knockout and MGME1 + EXOG double knockout cells, with a notable increase 
in intensity in the double knockout at later days (day 6-10, Figure 24 b). 
 
3.4 Depletion effect of mitochondrial DNA by ddC in 
mitochondrial nuclease-deficient POLG and MGME1 clones 
Another way of inducing mtDNA depletion in human cells is the application of 
2’,3’-dideoxycytidine (ddC), which is a competitive inhibitor of POL γ as well as 
a terminator of the nascent strand during replication (Mancini et al., 1988, 
Steward et al., 2011). Optimized ddC concentration was determined prior this 
experiment through a killing curve, performed over one week on mitoEagI HEK 
cells (data not shown). POLG knockin and MGME1 knockout mitoEagI HEK 
cells were therefore incubated in the presence of 400 µM ddC over six days. Each 
second day, medium was exchanged to refresh the ddC concentration. Total 
DNA was again treated with BamHI to linearize circular mtDNA and used for 
Southern blotting (Figure 25 a). Incubation with ddC showed over 90% depletion 
of mtDNA in control at day three (Figure 25 b). Depletion in POLG knockin and 
MGME1 knockout clones was delayed and reached similar 90% depletion levels 
only after four days. Smaller-sized mitoEagI and oriL fragments were visible in 
mutant clones due to the leaky mitoEagI expression, even without doxycycline 
induction (visible at zero hour and in the absence of ddC; not detectable in 
control, probably due to degradation effects) and showed similar persistency as 
the full-length fragment.  
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Figure 25: Depletion of mtDNA in POLG and MGME1 mutant HEK cells. a) Southern 
blot shows depletion of the mtDNA in control, POLG p.D274A and MGME1 ko cell lines over six 
days. Total DNA was treated with BamHI endonuclease to linearize circular, full-length 
mtDNA. Position of probe 1 is indicated by a black asterisk (*) on the simplified mitochondrial 
genome (right), close to the BamHI (B) cutting site. MitoEagI (E) and oriL fragments appear 
due to leaky expression of mitoEagI. b) Quantification of full-length fragment. Band intensity 
was compared to a nuclear ribosomal DNA (18S). 
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4. Discussion 
The degradation of linear mitochondrial DNA is presumably performed by 
mitochondrial exonucleases. The size evaluation of free ends from linearized 
mtDNA over time indicated a gradual degradation, starting from the free ends 
and then progressing over several thousand nucleotides, which is characteristic 
for the activity of exonucleases (Peeva and Blei et al., 2018). Still, the precise 
molecular machinery behind this mechanism is unknown. This work was 
dedicated to study the function of mitochondrial nucleases on mtDNA and to 
answer the question how linear mtDNA degradation, which is unique for the 
mitochondrial genome, is performed. My results give insights on the composition 
of the mtDNA degradation machinery, or ‘degradosome’, and show that POLG 
and MGME1 both perform pivotal tasks in this process. Other evaluated 
mitochondrial nucleases (APEX2 and EXOG) displayed no direct effect and are 
therefore not involved in this function, suggesting that enzymes, which are part 
of the mtDNA replication machinery, might be responsible not only for synthesis 
of mtDNA but for degradation of linear mtDNA as well. 
 
4.1 CRISPR/Cas9-editing creates stable human cell lines with 
altered mitochondrial nucleases 
Up to date it is not possible to directly modify the mitochondrial genome, using 
CRISPR/Cas9, to study effects of mitochondrial nucleases, as mitochondria 
apparently lack an endogenous mechanism of nucleic acid import, which is a 
prerequisite for CRISPR/Cas9 gene-editing (Gammage et al., 2017). Therefore, 
mitochondrial nucleases were used, which can also perform precise targeting of 
mtDNA, and introduce DSB’s to study linear degradation of mtDNA. However, 
the recognition site of mitochondrial endonucleases can not be designed as it is 
given on the mitochondrial genome sequence. 
CRISPR/Cas9-editing of mitochondrial exonucleases was performed in a human 
mitoEagI expressing cell line, which is usable for inducing mtDNA DSB’s and 
afterwards analysing the possible effects of dysfunctional mtDNA degradation. 
The CRISPR/Cas9-system proved to be an effective tool for permanently gene-
editing of mitochondrial nucleases in mitoEagI HEK 293 cells.  
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The method by Schmidt et al. (2015) allowed to create custom-built 
CRISPR/Cas9-vectors containing specific gRNA sequences against any nuclear 
gene of interest. It was reported that the Cas9 protein binds to the sgRNA and 
the protospacer region in a largely sequence-independent manner, but favouring 
protospacer regions with G/C rich regions at positions 17/18 (Schmidt et al., 
2015). Furthermore, sequences with A/T regions at positions 14/15 should 
display higher genomic editing activity (Schmidt et al., 2015). Although all 
knockout sequences (against MGME1, APEX2, EXOG) met the G/C condition 
(Table 10), only APEX2 fulfilled the A/T condition, but did not display a higher 
editing efficiency (Table 13). The importance of specific nucleotides at these 
positions is still elusive, as higher genome-editing activity was reported for 
sequences with G/C rich regions at positions 17/18, but not 14/15 (Wang et al., 
2014). Doench et al. (2014) showed similar results for positions 14/15, while 
presenting different findings for other positions. Schmidt et al., suspect that 
Cas9 activity chooses a favourable thermodynamic profile of either the 
protospacer region, the sgRNA:potospacer complex or the sgRNA molecule itself. 
To ensure that CRISPR/Cas9-editing successfully renders the targeted gene 
dysfunctional at the level of protein expression, the position of each sgRNA was 
chosen within the earliest possible exons and at least within the first half of the 
coding region of the gene. In consistency with previous reports from the 
literature (Wang et al., 2014, Doench et al. 2014, Schmidt et al. 2015), indel 
mutations by sgRNAs, targeting early exons, increase the efficiency of functional 
knockouts as they result in clear loss-of-function mutations. The targeted 
mitochondrial nucleases MGME1, EXOG and APEX2 showed frameshift indels 
(Figure 17) through exploitation of the NHEJ repair pathway in mitoEagI HEK 
cells. The 3’–5’ exonuclease activity of POLG was selectively silenced by 
introducing the p.D274A point mutation, by using a co-transfected 
oligonucleotide as template for homologous-directed repair. This mutation 
previously led to an elimination of the 3’–5’ exonuclease activity of POLG in 
yeast (Foury and Vanderstraeten, 1992), mice (Trifunovic et al., 2004) and flies 
(Bratic et al., 2015). The additional silent mutation for the PstI endonuclease 
restriction site greatly accelerated the pre-screening phase of the vast number 
of POLG clones. After Cas9 introduced the DSB, its repair through NHEJ is 
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usually performed within the first thirty minutes; HR on the other hand, takes 
over seven hours to complete the DSB repair (Mao et al., 2008). The large 
discrepancy in efficiency between both methods can be explained through the 
presence or absence of the co-transfected oligonucleotide, which serves as a 
repair template for homologous recombination. In its absence, no HR can be 
performed to introduce the desired p.D274A point mutation for POLG. It was 
crucial for studying linear mtDNA degradation, that occurring off-target effects 
produced by Cas9 did not interfere with the artificial expression of the mitoEagI 
protein in mutant HEK 293 cell lines. Recent studies, analysing CRISPR/Cas9-
mediated off-target effects on a genome-wide level in single cell clone revealed 
deviating number of incidences for this event, depending on the cell line: In 
human pluripotent stem cell (hPSC) clones, the risk for off-target mutations 
were very low and posed no significant concern for applications like disease 
research (Veres et al., 2014, Smith et al., 2014). However, in cancer cell lines, 
like K562 cells (human myelogenous leukemia cells) or HEK 293 cells, off-target 
effects have been reported to occur at much higher incidences (Fu et al., 2013, 
Hsu et al., 2013). The assessments in this study, regarding Cas9 off-target 
effects in HEK 293 cells, focused on potential harmful effects to the mitoEagI 
protein expression, since mitoEagI is required to linearize the mitochondrial 
DNA upon induction. No deficiencies were observed in any mutant HEK 293 cell 
line, neither in protein expression (Western blot, Figure 18) during the first 
twenty-four hours, nor in doxycycline-induced endonuclease activity on circular 
mtDNA (qPCR data, Figure 19). CRISPR/Cas9 engineering on MGME1 
produced two knockout clones with different indels, showing the same 
deficiencies of linear mtDNA degradation, which minimizes the chances that off-
target effects can be made responsible for this result. In the POLG knockin 
mutant, mitoEagI endonuclease activity was reduced due to genomic instability, 
but still sufficient enough to study linear mtDNA degradation, as Southern blots 
later showed the clear formation of smaller-sized fragments and the absence of 
their rapid degradation (Figure 20). 
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This demonstrates, that the CRISPR/Cas9-system proved to be a powerful 
technique for creating mutant mitoEagI HEK cell lines with permanently 
altered expression of mitochondrial nucleases, without damaging the mitoEagI 
endonuclease gene through off-target effects. The established mutant cell lines 
have to be re-evaluated over time for their efficient induction of mitoEagI, given 
the genomic instability of the HEK 293 cells, which increases especially in high-
passage lines.  
 
4.2 POLG and MGME1 perform linear mtDNA degradation 
Both, POLG and MGME1 are key enzymes responsible for mtDNA 
maintenance. Previously it was reported, that POLG and MGME1 are in 
physical contact (Nicholls et al., 2014) and MGME1 is known to cleave 5’-flaps 
for POLG during replication, while POLG processes 3’-flaps on its own to create 
ligatable ends (Uhler et al., 2015). Later it was shown, that MGME1 alone is 
poor at generating these ligatable ends, but exerts a very strong flap-processing 
activity, when in combination with POLG (Uhler et al., 2016). Uhler et al. 
argued, that interaction between Pol γ and MGME1 is dependent on the 3’–5’ 
exonuclease activity of POLG and that MGME1 is the sole nuclease in removing 
mtDNA flaps in coordination with Pol γ (Uhler et al., 2016). Therefore we chose 
POLG and MGME1 as prime targets in the search for participants of the 
mitochondrial degradation machinery.  
By studying the effects of deficient mitochondrial nucleases in the context of 
linear mtDNA degradation, I could show that POLG and MGME1 both play a 
major role in rapid linear mtDNA degradation. MGME1 possesses 5’–3’ 
exonuclease activity on single-stranded mtDNA and pathogenic mutations in 
MGME1 have been described to cause disturbances in mtDNA maintenance 
leading to multisystemic mitochondrial diseases (Kornblum et al., 2013, Nicholls 
et al., 2014). The mitochondrial polymerase γ possesses an exonuclease domain 
(POLG) with an additional 3’–5’ exonuclease activity, which is most often 
mentioned for its proof-reading activity, performing base excision repair, during 
replication (Foury et al., 1992). Under normal circumstances, damage to 
mtDNA, which is due to the formation of DNA double-strand breaks, results in 
the degradation of this particular, damaged mtDNA molecule. Since 
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mitochondria are unique in their multicopy genomic nature, degrading and thus 
losing a small percentage of its genome imposes no threat to the total 
mitochondrial genome of the cell. My data could show that linearized mtDNA 
remained largely intact during the first six hours after mitoEagI induction in 
MGME1 knockout and POLG knockin clones (Figure 20 and 18). The results 
between both mutant cell lines, displaying differences corresponding to the 
mitoEagI fragments raised the question whether this ‘degradosome’ can operate 
in both strand-directions simultaneously. 
 
In our recent publication, we could show, with ultra-deep sequencing of linker-
ligated mtDNA in MGME1 knockout and POLG knockin cells, six hours after 
inducing double-strand breaks, that MGME1 showed unaltered persistency of 
the non-degraded ends and POLG displayed over 80% of detectable ends within 
a distance of 600 base pairs from the cutting site (Peeva and Blei et al., 2018, 
Figure 3a).  A one-side-blunt double-stranded linker ligation to either native or 
T4-polymerase-blunted mtDNA showed similar quantities of detectable ends 
through ultra-deep sequencing (Peeva and Blei et al., 2018, Figure 3d-e). We 
therefore concluded, that the majority of non-degraded and partially-degraded 
mtDNA ends exist in vivo as blunt double-strands, as pre-treatment with T4 
polymerase would otherwise have drastically increased the number of ligatable 
ends. This suggested that bulk degradation of linear mtDNA occurs from the 
free ends and is performed by exonucleases (Peeva and Blei et al., 2018).  
It is interesting to speculate about the reasons for the different mtDNA ends 
between MGME1 and POLG mutants. The complete knockout in MGME1 
prevents 5’-flap processing and MGME1 mutant showed no signs of degradation 
on the ends, after linearization (Peeva and Blei et al., 2018, Figure 3a). Silencing 
the 3’–5’ exonuclease domain (POLG) from mitochondrial polymerase γ still 
prevents rapid degradation but displayed a slightly progressed degradation 
from the cutting site. Maybe the p.D274A point mutation of POLG does not 
completely inhibit the 3’–5’ exonuclease activity. It was reported, that MGME1 
cannot rescue ligation in POLG-/- cells and that coordination between Pol γ and 
MGME1 depends on POLG’s functional 3’–5’ exonuclease activity (Uhler et al., 
2016). Alternatively, mitochondrial nucleases like APEX2 or MRE11, both 
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possessing single-strand DNA 3’–5’ exonuclease activity, might compensate for 
the loss of POLG’s exonuclease activity. APEX2 predominantly localizes in the 
nucleus and only to some extend in mitochondria (Tsuchimoto et al., 2003) and 
it’s BER activity has not been demonstrated yet in mitochondria (Bruni et al., 
2016). Mitochondrial DNA repair pathways still raise several unanswered 
questions, especially on topics like mismatch repair and double-strand break 
repair. While NHEJ is undetectable in mitochondria (Tadi et al., 2016), an 
alternative pathway to NHEJ, known as microhomology-mediated end joining 
(MMEJ) utilizes microhomology regions for recombination, but also results in 
larger deletions in mitochondria (Tadi et al., 2016, Dahal et al., 2017). Dahal 
and colleagues compared the difference between MMEJ and homologous-
directed repair (HDR) in mitochondria and found a localization of the MRN 
complex (MRE11, RAD50, NBS1), RAD51 and Ligase III (LIG3) in mitochondria 
(Dahal et al., 2017). HDR results in an error-free repair without loss of 
sequences, while the error-prone MMEJ is performed, if the DSB is close to the 
direct repeat, used for HDR (Dahal et al., 2017). However, evaluation of our 
ultra-deep sequencing data revealed only break points caused by NHEJ, which 
were predominantly present as blunted ends after mitoEagI cleavage (Peeva 
and Blei et al., 2018). Yet, it was shown that MRE11 nuclease activity can be 
modulated in several ways, like through the presence of RAD50 or NBS1, but 
also through stimulation by ATP or sequence homology in the DNA substrate 
(D’Amours and Jackson, 2002). It remains a task for further studies to shed light 
on this topic how the mitochondrial maintenance machinery changes its mode 
of action during impaired mitochondrial nuclease activities. 
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In 2015, Bratic et al. already showed that recombinant human POLG proteins, 
expressed in insect cells can degrade small linear DNA fragments, in vitro, 
through exonuclease activity in the absence of deoxynucleotides (Bratic et al., 
2015). In recent results, knockdown of POLG in Drosophila prevented the 
elimination of the paternal mitochondrial genome during spermatogenesis (Yu 
et al., 2017), suggesting an additional function of the exonuclease domain for 
mtDNA maintenance. It is known, that T4 DNA polymerase can use its 3’–5’ 
exonuclease activity in the absence of deoxyribonucleotide triphosphate (dNTP) 
substrates to remove single-stranded DNA stretches (Huang and Lehman, 
1972).  
Very recent findings by Moretton et al. (2017) questioned the idea that known 
mitochondrial nucleases are involved in linear mtDNA degradation and instead 
suggest an undiscovered mtDNA degradation pathway performed by currently 
unknown mitochondrial nucleases (Moretton et al. 2017). After conducting 
knockdown studies on selected mitochondrial nucleases (ENDOG, EXOG, 
DNA2, FEN1, MGME1) in an inducible mitoPstI HEK 293 cellular model 
(similar to mitoEagI, but has two cutting sites inside the mitochondrial genome, 
removing a fragment of ~2110bp), Moretton and colleagues found no deficiencies 
in linearized mitochondrial DNA degradation. Our knockdown results on 
MGME1, POLG and TWNK in the mitoPstI model showed the formation of a 
prominent fragment after four hours of induction (Peeva and Blei et al., 2018 
Figure 2) – Moretton et al. evaluated the degradation effects after two hours, 
which might be another reason for the differences between both results. Before 
we used the CRISPR/Cas9 tool in mitoEagI HEK 293 cells to target 
mitochondrial nucleases, we also tried to perform knockdown studies with 
MGME1 in mitoEagI HEK 293 cells. Efficient knockdown of MGME1 was 
already achieved after three days at the mRNA level, but prolonged siRNA 
treatment over a total period of six days showed an additional depletion at the 
protein level. Still, evaluations on mtDNA depletion and accumulations of 7S 
levels still differed from the original findings by Kornblum et al. (2013). Western 
blot analysis on the selected mitochondrial nucleases performed by Moretton et 
al. also showed small levels of protein expression after three-day siRNA 
treatment (Moretton et al. 2017, Supplementary Figure 1), which likely explains 
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why no direct effects of MGME1 knockdown on linear mtDNA degradation were 
observed. Of note is, that doxycycline induction of HEK 293 cells did not 
influence the protein expression of neither the selected mitochondrial nucleases 
nor other mitochondrial proteins, like Twinkle or POLG (Moretton et al. 2017, 
Figure 1-2). 
Apart from our findings that POLG and MGME1 participate in linear 
degradation of mtDNA (Peeva and Blei et al., 2018), Medeiros et al. (2018) also 
showed very recently in starving cells of Saccharomyces cerevisiae, that POLG 
also displayed a strong 3’–5’ exonuclease-dependent mode of mtDNA 
degradation to adjust increasing mtDNA copy numbers during nucleotide 
limitations (Medeiros et al., 2018). Medeiros et al. proposed a central role for 
POLG in mtDNA copy number regulation in response to physiological changes 
by switching between the two opposing modes of replication and degradation 
(Medeiros et al., 2018). 
 
4.3 No additional mitochondrial nucleases, besides MGME1, 
influence rapid linear mtDNA degradation 
With POLG and MGME1 being the first identified candidates involved in linear 
mtDNA degradation, the question occurred if other mitochondrial nucleases 
with 3’–5’ or 5’–3’ exonuclease−activity could perform or support this task. Most 
mitochondrial nucleases have been described to perform flap-processing 
functions for mtDNA maintenance, including MGME1 (Kornblum et al., 2013). 
One set of possible nuclease candidates consists of FEN1 and DNA2, which 
showed increased flap processing efficiency in conjunction (Zheng et al., 2008, 
Uhler et al., 2015). Knockdown experiments on FEN1 and DNA2 however, 
showed no deficiencies on linear mtDNA degradation (Peeva and Blei et al., 
2018) and mitochondrial localization of FEN1 is even still debated (Bruni et al., 
2017). Holt and colleagues have reported a shorter isoform of FEN1, named 
FENMIT, that can bind, but not cleave RNA flaps (Kazak et al., 2013), which 
might substitute FEN1s activity in mitochondria. Three other nucleases are 
known, besides DNA2 and FEN1, which localize in mitochondria: ENDOG, 
EXOG and MGME1. EXOG can also exert a 5’–3’ exonuclease activity, just like 
MGME1, on ssDNA during SSB repair (Cymerman et al., 2008) and depletion 
Discussion 
80 
 
of EXOG was reported to cause persistent SSBs in mtDNA, enhanced ROS levels 
and apoptosis (Tann et al., 2011). This bears the question if EXOG can support 
or even substitute MGMGE1s task during linear mtDNA degradation. Likewise, 
it was shown that mtDNA elimination during spermatogenesis is dependent on 
ENDOG and POLG (DeLuca and O’Farrel, 2012). We demonstrated that neither 
the knockout of EXOG, nor the knockdown of ENDOG showed any effect on 
rapid degradation of linearized mtDNA (Supplementary Figure 4, Peeva and 
Blei et al., 2018).  
In the past, it was suggested that EXOG and ENDOG influence mtDNA 
depletion, initiated by Herpes Simplex Virus (HSV) 1-mediated mtDNA 
depletion, through its viral alkaline nuclease UL12.5 (Duguay and Smiley, 
2013), however HSV infection already causes major damage to the 
mitochondrial genome within a few days (Saffran et al., 2007) and therefore the 
additionally performed knockdown and overexpressing experiments on EXOG 
and ENDOG, by Duguay and Smiley might have shown only smaller depletion 
effects to the already greatly disturbed mtDNA maintenance machinery. 
Monitoring the 5’–3’ exonuclease activity of EXOG in a cellular model provided 
additional insights on EXOGs participation in linear mtDNA degradation. 
When looking for other nucleases with 3’–5’ exonuclease activity, like POLG 
(and besides MRE11), one finds APEX2, which predominantly localizes in the 
nucleus, but also in mitochondria (Tsuchimoto et al., 2001). APEX2 uses its 
3’–5’ exonuclease activity preferentially during mismatched base repairs 
(Burkovics et al., 2006) and is presumed to be involved in nuclear BER – even 
though mitochondrial activity has not been demonstrated yet (Bruni et al., 
2016). Together with EXOG, APEX2 both provide an additional set of nucleases 
which can perform 3’–5’ or 5’–3’ exonuclease activity and might therefore play a 
role in the degradation process of linear mitochondrial DNA. 
My experiments performed on APEX2 and EXOG knockout cell lines showed no 
signs of altered degradation on linearized mtDNA (Figure 22-21). Even the 
double-knockout of MGME1+EXOG showed no significant increased persistency 
of the linear fragment, resulting from the original mitoEagI ends in the 
prolonged time course experiments (Figure 24), compared to MGME1 knockout 
alone. Furthermore, knockdown experiments performed on ENDOG and MRE11 
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also showed no changes to regular linear mtDNA degradation (Peeva and Blei 
et al., 2018, Supplementary Figure 4), which altogether point towards POLG 
and MGME1 being the prime nucleases involved in mtDNA degradation. 
 
4.4 Linearized mtDNA fragments show signs of degradation in 
POLG and MGME1 mutants after the first 24 hours 
In order to gain a better understanding of mitochondrial DNAs degradosome, I 
performed long term degradation experiments, which put the scope beyond the 
first twenty-four hours of induced mitoEagI expression. Without doxycycline 
induction, mitoEagI expression should cease, apart from the leaky expression 
and only already expressed mitoEagI endonucleases would perform their DSB 
on the mitochondrial genome. This might give the cells the chance to replicate 
and recover their lost mtDNA. However, after one day, mitoEagI endonuclease 
activity linearized nearly the complete mitochondrial genome in all knockout 
clones and most of it in the POLG knockin mutant. Furthermore, half-life time 
of the mitoEagI protein after doxycycline induction stopped was not assessed, 
but could be performed through Western blotting. EXOG and APEX2 mutants 
had no mtDNA molecules left, to be utilized for mtDNA repair and replication. 
Yet it also seems that both exonucleases don’t have additional functions on 
linear mtDNA degradation. This would also explain why no additional effects 
were observable in the MGME1+EXOG double-knockout and suggest, that 
EXOG provides no compensatory mechanisms, in case of incapacitated MGME1 
exonuclease activity. The free ends in MGME1 and POLG mutants on the other 
hand could have been available, in theory, for mitochondrial DSB-repair, due to 
the absence of rapid degradation and in absence of induced mitoEagI 
endonuclease. The observed recurrence of the full-length fragment in POLG 
knockin at late days, could stem from the fact that a subcellular population lost 
the mitoEagI-expressing plasmid and overgrew the remaining cells. 
Alternatively, since induced mitoEagI expression was stopped through the 
medium change at day one, mtDNA maintenance was indeed able to repair the 
full-length fragment through HDR. Another possibility could be, that due to the 
loss of the exonuclease (and proof-reading) activity, mitochondrial polymerase γ 
might display an accelerated polymerase activity, resulting in faster 
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synthesized mtDNA, which now bears a lot of mistakes. A recent study, 
assessing the speed of mitochondrial DNA replication however, found no effect 
in mice with a deficient POLGD275A variant, that resulted in a lack of 
proofreading activity (Forslund et al., 2018).  
Another approach of eliminating the mitochondrial genome used the 
incorporation of dideoxycytidine (ddC), which inhibits mtDNA replication, 
either through acting as a terminator of nascent strand elongation or by being 
a competitive inhibitor of mitochondrial polymerase γ (Brown et al., 2002). Being 
unable to finish mtDNA replication leaves the terminated single-stranded 
mtDNA strand prone to linear mtDNA degradation, or strand-breaks, which 
ultimately results in a depletion of mitochondrial copy numbers, without being 
dependent on the expression of the mitoEagI endonuclease. Dideoxycytidine 
must be phosphorylated to its active triphosphate form by cytoplasmic kinases, 
before being transported into the mitochondria, to inhibit mtDNA replication 
(Brown et al., 2002). In my previous experiments, circular mtDNA was cleaved 
by mitoEagI endonuclease and showed a complete linearization of mtDNA 
during the first twenty-four hours in all tested cell lines. Here, depletion of 
circular mtDNA progressed at a much slower pace, as incorporation of ddC and 
subsequently terminated strand synthesis can only occur during replication of 
intact mtDNA, which takes between one and two hours to complete an entire 
cycle of replication (Clayton, 1982). There was a small effect observable on linear 
degradation of mtDNA between day three and day four, delaying the depletion 
of mitochondrial copy numbers in both POLG and MGME1 mutants compared 
to control (Figure 25). The inhibition of POLGs exonuclease domain by ddC has 
not been demonstrated yet, only for other chain-terminating dideoxynucleoside 
analogues (Bridges et al., 1993, Gray et al., 1995). A previously reported slower 
depletion rate of mitochondrial copy numbers in MGME1-/- fibroblasts 
(Kornblum et al., 2013), suggesting an impaired mtDNA breakdown, could not 
be replicated in mitoEagI HEK cells. Perhaps the major difference in ddC 
concentration (20-times higher than in fibroblasts) or the genomic instability of 
the HEK 293 cell line influenced the possibility of discovering this finding. 
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4.5 TWNK, POLG and MGME1 compose the mitochondrial 
‘degradosome’ 
Overall, these findings present strong evidence for the involvement of POLG 
and MGME1 in linear mtDNA degradation. Since both enzymes are part of the 
mtDNA replication and maintenance machinery, the question occurs if other 
members from it might play a role in degradation, too. In order to expand single-
stranded mtDNA and allow continuous replication or degradation, first, double-
stranded mtDNA must be unwound by the mitochondrial helicase Twinkle. 
Without TWNK, only overhangs resulting from DSB, could be processed. We 
addressed this question in our recent publication and performed knockdown 
experiments on TWNK in mitoPstI HEK 293 cells, which showed severe 
impairment of rapid degradation on linearized mitochondrial DNA (Peeva and 
Blei et al. 2018 Figure 5b), even with a small fraction of protein expression for 
Twinkle remaining (15% expression after TWNK knockdown, Peeva and Blei et 
al. 2018 Supplementary Figure 6). Together these findings strongly suggest that 
rapid linear degradation of linearized mitochondrial DNA is performed by the 
same enzymes, which are involved in replication of mtDNA. This implies novel 
additional roles for the enzymes TWNK, POLG and MGME1, which are 
normally part of the mtDNA replication and maintenance machinery (Figure 
26).  
Future studies could investigate factors, which are relevant to switch the 
mtDNA maintenance machinery from performing replication towards 
degradation. Different types of template mtDNA (free double-stranded ends 
being degraded versus single-stranded 3’ ends initiating replication) or protein 
factors could be among these factors. The accessory subunit POLG2 does not 
seem to be required for POLG to perform degradation (Peeva and Blei et al. 2018 
Supplementary Figure 4), despite the fact that it is necessary for replication, 
indicating that the interaction between POLG and POLG2 could be another 
regulatory element. 
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Figure 26: Models of replication and double-strand degradation of mtDNA by the same 
machinery. TWNK, POLG and MGME1 play a role in replication (upper panel) and 
degradation (lower panel) of mitochondrial DNA. During replication, the polymerase activity of 
POLG determines the overall movement speed of the machinery. Here, MGME1 removes flap 
structures and creates ligatable ends. Upon degradation, net movement is reversed and 
correlates to the exonuclease activity of POLG (Figure adapted from Peeva and Blei et al., 2018). 
 
Concluding, this thesis in conjunction with our recent publication (Peeva and 
Blei et al., 2018) presented strong evidence for a novel mechanism in 
mitochondrial DNA maintenance, which expands our knowledge on linear 
mtDNA degradation and the formation of mtDNA rearrangements. 
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